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ABSTRACT
Peptide microarrays have been used in molecular biology to profile immune re-
sponses and develop diagnostic tools. When the microarrays are printed with random
peptide sequences, they can be used to identify antigen antibody binding patterns
or immunosignatures. In this thesis, an advanced signal processing method is pro-
posed to estimate epitope antigen subsequences as well as identify mimotope anti-
gen subsequences that mimic the structure of epitopes from random-sequence pep-
tide microarrays. The method first maps peptide sequences to linear expansions of
highly-localized one-dimensional (1-D) time-varying signals and uses a time-frequency
processing technique to detect recurring patterns in subsequences. This technique is
matched to the aforementioned mapping scheme, and it allows for an inherent anal-
ysis on how substitutions in the subsequences can affect antibody binding strength.
The performance of the proposed method is demonstrated by estimating epitopes and
identifying potential mimotopes for eight monoclonal antibody samples.
The proposed mapping is generalized to express information on a protein’s se-
quence location, structure and function onto a highly localized three-dimensional
(3-D) Gaussian waveform. In particular, as analysis of protein homology has shown
that incorporating different kinds of information into an alignment process can yield
more robust alignment results, a pairwise protein structure alignment method is pro-
posed based on a joint similarity measure of multiple mapped protein attributes. The
3-D mapping allocates protein properties into distinct regions in the time-frequency
plane in order to simplify the alignment process by including all relevant information
into a single, highly customizable waveform. Simulations demonstrate the improved
performance of the joint alignment approach to infer relationships between proteins,
and they provide information on mutations that cause changes to both the sequence
and structure of a protein.
i
In addition to the biology-based signal processing methods, a statistical method
is considered that uses a physics-based model to improve processing performance. In
particular, an externally developed physics-based model for sea clutter is examined
when detecting a low radar cross-section target in heavy sea clutter. This novel model
includes a process that generates random dynamic sea clutter based on the governing
physics of water gravity and capillary waves and a finite-difference time-domain elec-
tromagnetics simulation process based on Maxwell’s equations propagating the radar
signal. A subspace clutter suppression detector is applied to remove dominant clutter
eigenmodes, and its improved performance over matched filtering is demonstrated
using simulations.
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Chapter 1
INTRODUCTION
1.1 Introduction and Motivation
Detection methods determine whether or not an observed noisy signal consists
of useful information. Once information is detected, then information parameters
need to be estimated, or specific information patterns need to be identified. One
approach to improving detection performance is to first process an observed signal
before applying statistical methods designed to determine the presence of a signal in
noise. Signal processing techniques are most useful when they are designed to match
the properties of the observed signal or when they can apply a physical-based model
that describes the observation medium.
In this dissertation, we consider two detection applications that benefit from
matched signal processing techniques, or techniques that rely on physics-based mod-
els. The first application is in molecular biology, and it involves mapping one-
dimensional (1-D) protein sequences or three-dimensional (3-D) protein structures
onto signals with highly-localized representations in the time-frequency plane. Using
processing techniques that are matched to these mapped signals can provide impor-
tant information for identifying diseases or for drug discovery. The second application
involves detecting small radar targets in heavy sea clutter. Using a dynamic model for
generating sea clutter based on the governing physics of water gravity and capillary
waves provides useful information for improving the target detector design.
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1.2 Signal Processing Methods in Molecular Biology
The area of bioinformatics is mainly involved with the management of biological
information using computer technology and statistics. Signal processing for molec-
ular biology, on the other hand, encompasses the development of algorithms and
methodologies for extracting, processing and interpreting information from biological
sequences [3–8]. Intelligent use of signal processing algorithms can provide invaluable
insight into the structure, function and evolution of biological systems. For example,
complex assays that determine the functional activities of analytes or peptide chips
that manifest key residues for protein binding can provide a wealth of information on
underlying biological systems. However, in each of these cases, appropriately designed
processing is required to robustly extract the most relevant information. Images of
array fluorescence are enhanced to improve the estimation of gene reactivity, while
gene expression classification performance is increased by including biological and
experimental variability in the algorithm design [6].
Genomics and proteomics, in general terms, study the functions and structures
of genomes and proteomes, respectively. Genomes, which are genetic material of
organisms encoded in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), and
proteomes, which are expressed proteins in given organisms, provide discrete infor-
mation, represented in sequences of unique molecules [9, 10]. More specifically, DNA
are bio-molecules that are represented as letter sequences of precise orderings of four
nucleobases; the different orderings correspond to patterns that influence the forma-
tion and development of different organisms. Similarly, proteins are bio-molecules
represented as sequences of unique orderings of twenty linked amino acids, with each
amino acid represented by a letter of the alphabet.
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DNA and protein sequence analysis requires significant processing of the discrete
gene orderings in order to identify intrinsic common features, or find gene variations
such as mutations [11, 12]. One important application in genome analysis is the
identification of gene sequence periodicity; this periodicity selects regions of genetic
repetition that have been shown to correlate with functionally important genes [13,
14]. Gene periodicity has been analyzed using spectral methods [15–18]; such methods
have also been used to estimate variations in base pair frequencies between organisms
as they can indicate phylogenic origin from the species genome. Time-frequency
(TF) signal processing methods such as wavelet transforms have also been used in
gene sequencing to characterize long range correlations or identify irregularities in
DNA sequences [19, 16, 20].
Signal processing methods have also been used for sequence alignment. This is
a method for ordering sequences to identify regions of similarity due to functional,
structural, or evolutionary relationships between the sequences [21, 22]. As thousands
of organisms have been sequenced completely, and many more have been partially
sequenced, searching for these similarities requires a vast number of computations.
There are many algorithms designed to perform these searches including dynamic
programming algorithms such as Smith-Waterman, basic local alignment search tool
(BLAST), correlation based methods, Bayesian approaches, and TF based methods
[23–27, 12, 28–30]. Computational alignment tools based on dynamic programming
such as the Smith-Waterman algorithm are guaranteed to find all similarity matches,
but they are slow and inefficient [23]. Other tools, such as BLAST [24, 25], are
widely made available for database similarity searching as they were developed to
provide a fast approach of approximating the complete alignment found by dynamic
programming algorithms. BLAST runs very quickly, around an order of magnitude
faster than the complete alignment algorithms, and finds most significant alignments
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under most circumstances. However, it tends to miss alignments for queries with
repetitive segments. Correlation based methods map DNA or amino acid sequences
to sequences of real or complex numbers and use correlation between sequences of
numbers to compute similarity [28]. Correlation algorithms can be implemented ef-
ficiently using the fast Fourier transform; however, errors increase when aligning se-
quences of longer lengths. We have recently developed a TF based method that first
uniquely maps DNA or amino acid sequences to highly-localized Gaussian waveforms
in the TF plane and then uses the matching pursuit decomposition (MPD) algorithm
to perform alignment [30–32]. The TF-based alignment approach was compared to
other approaches and was shown to perform well with repetitive segments in real time
without pre-processing.
In addition to gene sequencing, microarray analysis has also played a significant
role in the extraction and interpretation of genomic information. Microarrays can
provide measurements of expression levels of large numbers of genes. For example,
peptide microarrays have been used to study binding properties and functionality
of different types of protein-protein interactions and to provide insight into specific
pathogens [33–37]. Peptide microarrays are a relatively new application in biological
signal processing. The technology to create assays using single peptide chains has been
around for a while in the form of the enzyme linked immunosorbent assay (ELISA)
[38]. In recent years, as the cost of printing many peptide clusters onto a single
substrate has been dropping, tens or hundreds of thousands of peptide clusters can be
reasonably printed on a single array. In addition to being able to construct large scale
peptide arrays to detect specific diseases, another important aspect are robust analysis
methodologies used to interpret and analyze the extracted peptide data in order
to establish relationships between peptide sequences and binding strengths. Some
of these methodologies include support vector machine (SVM) modeling methods
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[39], computational alignment approaches [40] and statistical tools such as t-test and
analysis of variance linear regression [41–43].
1.3 Epitope and Mimotope Estimation Methods
The human body’s response to a foreign pathogen is a complex process of creat-
ing cells to identify, inhibit, and eventually destroy the pathogen. Antibodies play an
integral role in this response, as their primary function is to recognize and neutralize
pathogens and alert the immune system on the pathogen’s presence. Antibodies, act-
ing as pathogen biomarkers, can be detected by locating the pathogen binding site or
epitope [44, 45]. As antibodies can recognize epitopes of multiple amino acids (AAs)
in length, each peptide may have several such binding sites. As a result, mapping
antibody epitopes on a target pathogen is very critical in diagnosing diseases. Mimo-
topes are peptides that mimic antibody binding sites and have binding characteristics
similar to epitopes [46]. In particular, an antibody for a given epitope antigen re-
sponds similarly to both the epitope and its derivative mimotope. Mimotopes have
been shown to induce an epitope antigen response with vaccination [47, 48] and thus
have the not yet realized potential to be used in developing new vaccines and diagnos-
tics. It is also possible to design methods for mapping mimotopes to a source antigen
in order to find the interacting epitope on the antigen [49].
There are a number of existing research tools that can be used to provide infor-
mation about a pathogen’s epitope as well as the binding strength of the antibody-to-
pathogen interface and the effect of changing the epitope sequence on the antibody
binding strength. Some of the more frequently used tools to study pathogens by proxy
of the antibodies include ELISA [50], phage display combined with peptide panning
[51–54], and peptide microarrays. Phage display results in a single epitope estimate
which is likely to be the strongest binder to the targeted antibody. Phage display
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can also be combined with peptide panning to further refine the epitope estimate by
measuring the binding strength of a set of peptide sequences which are single AA
substitutions from the phage display estimate of the epitope. Peptide microarrays
are printed with either a set of peptides from a sequenced proteome [37] or from
adaptations on known epitopes [36]. They are commonly used to profile the humoral
immune response by finding the antigenic regions of a proteome. Highly binding pep-
tides are antigen candidate sequences that are further verified by checking which of
the sequences are on the folded protein surface and are physically available to an anti-
body for binding. Epitopes are efficiently mapped using peptide microarrays acting as
screening tools for profiling antibody signatures and discovering diagnostic signatures.
Peptide microarrays are designed to diagnose a specific infectious disease pathogen,
assuming that the pathogen has already been identified and sequenced before the
microarray is designed. Mimotopes have thus far been discovered by phage display
technology [51], and mimotope databases have been developed based on information
acquired from phage display [55, 56].
The recently developed random-sequence peptide microarrays provide platforms
for identifying antigen antibody binding patterns or immunosignatures [44, 57, 58].
These microarrays have a major advantage over tests designed for one specific an-
tibody as they adopt an unbiased sampling of hundreds of thousands of random,
but known, peptide sequences. These random-sequence peptides are important for
recognizing multiple antibodies from pathogens present in the testing blood sample,
without any a priori knowledge of a specific disease. As a result, they can be used to
classify different diseases based on identifying patterns of peptides that exhibit high
image pixel median fluorescence intensity (MFI) in the microarray. From the MFI of
the aggregate set of peptides, it is possible to estimate antibody epitope sequences and
obtain their corresponding binding strength. Specifically, peptides with the highest
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MFI are composed of specific binding to sub-sequences which match antigen epitopes
or potential antigen mimotopes. The fluorescence patterns for pathogens have been
shown to be consistent across patients and thus can act as biomarkers to classify
patients into disease groups [59–63].
Epitope and mimotope estimation has been attempted before on smaller arrays
with 5,520 and 10,000 peptides [34, 44]. The peptides with the largest binding
strength tended to resemble the true epitopes, but with so few peptides, exact epitope
sub-sequences of more than a few AAs did not exist on these smaller arrays. Increas-
ing the number of peptides on the array increases the number of unique sub-sequences
on the array as well as the number of times that those sub-sequences are repeated.
Arrays with 100,000 or more peptides contain enough unique sequences to estimate
exact epitopes with a high degree of reliability and robustness, and thus are adequate
for diagnosing diseases from sequenced proteomes [64, 65]. Furthermore, given that
random sequence peptides can yield mimotopes for many different antigens [66], many
disease associated antigen could, in theory, be detected.
A challenge of analyzing random-sequence peptide microarrays is how to integrate
peptide sequences and MFI measurements to estimate epitopes or identify mimotopes.
NNAlign is an algorithm which attempts to solve this problem by generating neural
network models from subsets of the peptide array data and then combining those
multiple models into a single motif [67]. This algorithm provides a representation
of AA probabilities at each position in the estimated motif. Another method for
motif/epitope estimation uses regular expressions, a formally defined sequence of
characters which forms a search pattern, to estimate epitopes. This method includes
a dependence on the sub-sequence position within the peptide sequence [2].
Random sequence peptide arrays are in contrast to panned peptide arrays which
start from epitope candidate sequences either derived from phage display, the pro-
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teome of the pathogen of interest. Proteome sub-sequences are printed on arrays
as individual peptides [68], and epitope candidates from phage display and random-
sequence peptides are printed on the array with exhaustive substitutions and trun-
cations to find minimal length, exact epitope sub-sequences [69, 70]. However, these
methods require and initial step that can be computationally intensive, can prohibit
comprehensive specificity analysis, and can limit the biological search space. For ex-
ample, if the search is limited to only linear sequences of a pathogens proteome, the
methods may not be able to identify conformal epitopes that can be detected in large
random sequence peptide arrays. Additionally, not all antibodies are linear sequences
to proteins, or are even necessarily in response to proteins, making it difficult to
determine a suitable peptide panning set.
1.4 Processing of Protein Structures
Protein alignment methods are used to arrange protein sequences or structures to
identify regions of similarity or homology between proteins with common function,
structure or evolutionary relationships. These methods are important not only for
drug discovery but also for providing associations between gene mutations and dis-
eases. Early pairwise protein alignment methods were based on the protein’s primary
structure or 1-D amino acid sequence [71–73]. Sequence protein alignment provides
some degree of similarity accuracy but can have a difficult time matching dissimilar
sequences which result in similar 3-D folded structures. Protein structures demon-
strate different shapes due to the hydrogen bonds, ionic bonds, and van der Waals
attractions between the molecules that make up the amino acids. The invention of x-
ray crystallography provided atomic coordinate information. As a result, alignments
are also performed using protein secondary and tertiary structures to improve match-
ing algorithm performance [74–76]. Recent research into protein alignment focuses on
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developing methods that integrate multiple protein attributes in order to improve the
evolutionary relevance between the identified matches [77–80]. Finding protein simi-
larity in sequence, function and structure can lead to accurately inferencing distantly
related homologs for which only some of the protein’s functions may be conserved and
to decreasing the number of structurally similar matches that have no evolutionary
relationship.
The integration of multiple protein information, when available, can aid in de-
termining homology and contributing to protein functionality [81]. Such information
includes amino acid sequences [77], hydrophobicity and structural factors [82–85],
hydrogen bonding potential and structural substitution matrices [80, 86], proteins
geometrical location [78, 79], and protein domains [87]. Note, however, that integrat-
ing the different information is not a simple problem. There is no known optimal
method to perform the integration and different integration methods yield different
matching results [78, 75]. In [74], a method is provided that takes into consideration
both protein sequence and structure information. The method models the evolution-
ary cost of protein mutations, insertions and deletions that occurred on the structure
level during transformation as implied by changes in the protein sequences. Struc-
ture alignment can be taken into consideration for amino acid substitution matrices
such as local substructure mutation matrices and hydrogen-bonding similarity. The
alignment accuracy for different types of information is a function of how distantly
related the proteins are. Amino acid sequence information is more useful for closely
related proteins, while more distantly related proteins require supplemental structure
information [80].
Traditional bioinformatic methods of protein sequence and structure pattern match-
ing can be computationally intensive due to the large amounts of proteomic data
available in reference databases. An approach toward this problem is the use of
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signal processing techniques for protein alignment after appropriately mapping the
protein element representations [6, 30, 88, 89]. In [30], a robust querying algorithm
is used based on a time-frequency signal expansion matched to the waveforms in
the mapped protein sequences. This approach is shown to outperform current-used
sequence alignment methods such as BLAST for queries with repetitive sequence
segments [90]. A 3-D Gaussian waveform is considered in [88] for protein structure
alignment, with each waveform mapping an individual amino acid. Graph theory and
additional properties of the protein are utilized in [91]. In [89], a 3-D waveform match-
ing algorithm is provided for local and global alignments between multiple protein
structures. In this approach, linearly separable, highly-localized Gaussian waveforms
are used to map links between amino acids with inherent directionality information.
1.5 Sea Clutter Radar Signal Processing
The detection and tracking of small targets on the sea surface is difficult, as
strong scattering from the sea can mask weaker target reflections. In particular, at
low grazing angles and high sea states, transmitted signals with bandwidths large
enough to observe reflections from breaking waves and sea spikes can result in a low,
or even negative signal-to-clutter ratio (SCR) [92]. In such heavy sea clutter scenarios,
the detection performance deteriorates and the targets cannot be realistically tracked.
Increasing the received signal power through antenna gain, transmitter power, and
pulse Doppler processing may not improve detection as sea clutter returns consist of
the transmitted signal undergoing small Doppler shifts relative to the target.
One approach to improving target detection performance at low radar cross section
(RCS) is by accurately modeling the sea clutter statistics. This was demonstrated in
prior work using the compound Gaussian model that relates back to the physical sea
clutter phenomenology [93]. The model assumes that the sea clutter return consists
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of speckle and texture components. The speckle return is primarily a function of
small-scale capillary waves forming a large number of independent scattering from
the incident signal. The texture is a function of the large-scale gravity waves; it is
assumed to modulate the local mean power of the speckle return, while exhibiting
spatial correlation based on the range resolution, sea state, and wind speed [94]. The
compound Gaussian model has been validated using real sea clutter data, and has
been used to construct improved detectors and configure waveforms [95–97].
1.6 Dissertation Contributions
In this dissertation, we have three main contributions, summarized as follows.
1.6.1 Epitope Estimation and Mimotope Identification For Random Sequence
Peptide Microarrays
We propose a signal processing based method for epitope estimation and mimotope
identification using random-sequence peptide microarrays. In particular, we select an
appropriate time-domain basis signal to map the AAs in a peptide sequence. For a
unique mapping, we transform the highly-localized Gaussian signal in the TF plane;
we then map transformation parameters, such as time and frequency shifts to AA
characteristics, such as type, position in the sequence, and rate of change of type over
time. Signal processing is an established area of research in electrical engineering
for processing time-domain signals. Furthermore, a multitude of algorithms have
already been developed and evaluated for analyzing, detecting, estimating, identifying
and classifying signals. As a result, once peptide sequences are mapped to time-
domain signals, the problem is to select the appropriate algorithms for finding exact
and single-substitution matches between peptide sequences and and peptide sub-
sequences. We use the number of times a sub-sequence is found to occur in a random-
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sequence for epitope estimation and mimotope identification. The number of times
a single substitution sub-sequence occurs is used to determine the effects of single
AA substitutions on epitope and mimotope binding strength. Note that we have
successfully applied the TF mapping approach for DNA alignment and showed that
it outperformed BLAST in some alignment cases [30].
1.6.2 Generalized Mapping for Protein Multi-Alignment
We propose a signal processing based protein alignment approach to search for
similarities and establish homology by integrating information from multiple protein
attributes. Specifically, we perform alignment by integrating information from pri-
mary sequences to model the process of sequence evolution by mutations, insertions
and deletions; from geometric structures to provide similarity between 3-D shapes;
and from amino acid physical-chemical features, such as hydrophobicity, since the
pattern of hydrophobic residues in substitution matrices can provide alignment in-
formation of distantly related proteins. Variation in physical-chemical properties
can lead to substitution patterns represented by matrices including the codon sub-
stitution matrix, Dayhoff evolutionary mutation matrix, hydrophobicity amino acid
substitution matrix and block substitution matrix (BLOSUM) [84]. An amino acid
substitution matrix can, for example, show that hydrophilic amino acids are more
frequently substituted by hydrophobic amino acids than the vice versa scenario [86].
Also, predicting the effects of amino acid substitutions can lead to information on
protein function [98].
As proteins have distinct 3-D geometrical shapes, our signal processing based
approach first models the protein secondary or tertiary structure as a linear combi-
nation of 3-D Gaussian waveforms, following our initial work in [89]. The Gaussian
waveform provides a compact time-frequency representation while encoding the 3-D
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position of a protein’s α-carbons. The covariance matrix of the Gaussian waveform
is designed using pairwise angles between two neighboring α-carbons. Time-shifting
the Gaussian waveform provides information on the 3-D coordinates of the two amino
acids; frequency-shifting the Gaussian waveform provides directionality by pointing
between neighboring α-carbons. Additional transformations of the Gaussian wave-
form in the higher-order time-frequency plane can be used to map different protein
attributes. These attributes include the 1-D protein sequence, that characterizes the
location of covalently linked amino acids, and numeric amino acid physical-chemical
features, such as substitution matrix entries that could lead to protein function in-
formation. Note that multiple features, such as entries from different substitution
matrices, could be represented by additional unique waveform transformations. The
three protein attribute mappings, location, structure, and function (LoStrFn) provide
unique representation methods for performing multi-alignment (or alignment based
on multiple attributes) not only based on denotation and geometric similarities but
also on property similarity leading to different protein functions.
1.6.3 Physics-based Sea Clutter Model For Improved Target Detection of Low
Radar Cross-Section Targets
In this dissertation we present the detection results using an externally developed
physics-based sea clutter generation model based on an electromagnetic simulation of
gravity and capillary waves evolving through time. By computing radar returns from
the simulated sea surface and low RCS target scattering, we utilize the statistical
variation of the returns to separate the target from the clutter and thus improve
target detection performance. We specifically compare the performance of a matched
filter detector to that of a subspace clutter suppression detector [97]. The subspace
clutter suppression detector is an eigenmode analysis algorithm that exploits the
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statistical independence of clutter compared to the target of interest [99, 100]. As we
demonstrate, this detector can separate and suppress clutter from the radar returns,
significantly improving SCR and detection performance.
1.7 Dissertation Organization
This dissertation is organized as follows.
In Chapter 2, we first discuss the immunosignature data collection procedure
and explain how we form the peptide subsequences. We describe the amino acid to
signal mapping technique and provide details on our proposed peptide subsequence
estimation algorithm. We provide and discuss our findings on epitope estimation and
mimotope identification using data from monoclonal antibody (mAb) array samples.
We also discuss the different factors that affect the algorithm performance.
In Chapter 3, we first provide the protein-to-waveform mapping model for the
location, structure, and functional attributes of a protein. We then describe the 3-D
alignment in terms of the structure, sequence, and hydrophobicity alignment. We
demonstrate our results using two human mutant ferrochelatase proteins, showing
how the structure and functional attributes improve alignment.
In Chapter 4 we first provide the physics-based finite-difference time-domain sea
clutter simulation model based on Maxwell’s equations and define the environmental
and target parameters that define the strong sea clutter, and electromagnetically
weak targets under study. We consider the problem of detecting these low radar cross
section targets and define the generalized matched filter detector. We then present the
better performing subspace cutter suppression detector, and we provide simulations
demonstrating the detection performance of the two detectors under different modeled
sea clutter scenarios.
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Finally, Chapter 5 summarizes the work presented in this dissertation, provides
some concluding remarks, and comments on future directions for these lines of re-
search.
In Appendix A we provide a comprehensive list of all of the acronyms used in this
dissertation. In Appendix B we list the full results of our subsequence estimation
algorithm for all of the monoclonal antibody samples, and in Appendix C we provide
some preliminary epitope estimates for random sequence peptide array data collected
using blood samples of patients infected with different diseases.
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Chapter 2
EPITOPE ESTIMATION AND MIMOTOPE IDENTIFICATION USING
RANDOM SEQUENCE PEPTIDE MICROARRAYS
2.1 Immunosignature Random-Sequence Peptide Microarrays
The random-sequence peptide microarrays are designed by the Center for Inno-
vations in Medicine at the Biodesign Institute at Arizona State University [101].
The data corresponds to immunosignatures from eight different monoclonal antibody
(mAb) samples. The immunosignature assay is performed by incubating diluted blood
antibodies on a microarray of random-sequence peptides. The peptides are printed
on standard glass slides or synthesized onto silicon dioxide wafers and diced into
standard slides [101]. The 330k random-sequence peptide microarrays have 330,034
probes manufactured by HealthTell, Inc. in Chandler, AZ. The sequences are suffi-
ciently long such that binding occurs between an antibody and a subsequence of the
peptide, but not the entire peptide sequence. The average length of the peptide se-
quences on the 330k microarray is 11.2 amino acids (AAs), with a standard deviation
of 1.3 AAs. More specifically, 95% of the peptides are between 5 and 14 AAs long;
the minimum and maximum lengths are 1 and 22 AAs, respectively. From the 20
AAs, the AAs cysteine, isoleucine, methionine, and threonine are not included in the
selection. Note that these lengths do not include the constant AA linker sequence
GSG (glycine-serine-glycine), which attaches the AA chain to the array substrate.
The arrays are first washed in dimethylformamide for an hour. The solvent phase
is transitioned to an aqueous phase over a six hour period using a phosphate-buffered
saline incubation buffer before incubating in the presence of antibodies or serum. In
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order to bind the antibodies to the arrays, the arrays are washed in distilled water and
then loaded into a multi-well 24-up gasket. Each well receives an incubation buffer and
diluted sera solution containing antibodies. A secondary fluorescing antibody is added
to bind to the appropriate primary antibody. After incubation for an hour, the arrays
are washed using a plate washer. The removed arrays are scanned and the resulting
images are processed to provide raw microarray image data. The amount of antibody
binding to a feature measured remotely by fluorescence; more signal results when
more primary antibodies bind to the peptide and thus more secondary antibodies
bind to the primary antibodies. A calibrated picture is taken of the fluorescing array,
where pixels in the image have been associated with specific peptide clusters. The
median fluorescence intensity (MFI) is calculated as the median value of the pixels
associated with a given peptide cluster.
2.2 Forming Peptide Subsequences
Our objective is to detect and identify subsequences or their single AA substi-
tutions from a microarray peptide sequence. The subsequences could correspond to
epitopes or mimotopes of a specific pathogen. We consider an immunosignature mi-
croarray consisting of M peptide sequences; we denote the mth peptide sequence of
length Lm as Vm,m= 1, . . . ,M . As the maximum number of AAs in a peptide se-
quence is 22 using the 330k microarray, the maximum value of Lm = 22. By shifting
one AA at a time in the mth peptide sequence, we obtain at most Nm ≤ (Lm−L+1)
unique, length L, subsequences of Vm. In particular, the `th shifting operation,
`= 1, . . . , Nm, generates the `th subsequence, whose first and last AAs correspond to
the `th and (`+L)th AAs of the peptide, respectively. We denote the aforementioned
shifting function by h`(Vm;L), `= 1, . . . , Nm, m= 1, . . . ,M . This function generates
the length-L `th subsequence of the mth peptide Vm in the array by shifting the
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starting position of the subsequence from the first AA position of the peptide to the
`th AA position of the peptide. Using this function, we represent the `th unique
subsequence of Vm as
χ(`; dm,L) = h`(Vm;L) . (2.1)
Here, dm is the MFI of the mth peptide sequence Vm; it is the same value for
all subsequences of peptide Vm. For example, considering the Lm = 10 AAs long
peptide Vm=ARVYHKHKHE, we can generate at most (Lm − L + 1) = 8 unique sub-
sequences of length L= 3. The subsequences are χ(1; dm, 3)=ARV, χ(2; dm, 3)=RVY,
χ(3; dm, 3)=VYH, χ(4; dm, 3)=YHK, χ(5; dm, 3)=HKH, χ(6; dm, 3)=KHK, χ(7; dm, 3)=HKH,
χ(8; dm, 3)=KHE. Since two of the subsequences are identical, χ(5; dm, 3) = χ(7; dm, 3)
= HKH, then the number of unique sequences is Nm = 7.
To achieve our objective, we find the number of times each unique subsequence
of length L is repeated on the microarray. We form all possible unique subsequences
as the union of all subsequences from the M microarray peptides. Specifically, there
are at most J ≤∑Mm=1Nm unique subsequences, χj, j= 1, . . . ,J , in the set
SL =
M⋃
m=1
Nm⋃
`=1
χ(`; dm,L) . (2.2)
Note that, in practice, it is uncommon for a single peptide to contain repeated sub-
sequences; even when this occurs, it is only for the smaller length subsequences of
L= 4 or L= 5 AAs. It is much more common that different peptides share the same
subsequences.
2.3 Time-Frequency Mapping of Peptide Subsequences
The proposed peptide subsequence estimation algorithm is based on first mapping
the peptide AAs to unique signals and then using time-frequency (TF) signal pro-
cessing techniques to detect recurring patterns. The mapping uses the basic Gaussian
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signal, gb(t) =pi
−1/4 exp (−0.5 t2), t ∈ (−Tg, Tg), as it is the most localized signal in
the TF plane. The effective duration 2Tg is normally chosen to ensure minimum
computational processing complexity. The basic Gaussian signal has unit energy and
is centered at the TF origin. We design the AA-to-signal mapping as follows. Con-
sidering Nm subsequences of length L formed from the mth peptide Vm of length Lm,
we map each AA to the time-shifted and frequency-shifted Gaussian signal
g(t; l, k) = gb(t− lT ) exp (j2pikFt), t ∈ (lT − Tg, lT + Tg) . (2.3)
The time shift parameter lT is used to represent the lth AA in the peptide subse-
quence, l= 1, . . . ,L. The frequency shift parameter, kF , k= 1, . . . , 20, is used to map
the 20 existing AAs, as shown in Figure2.1. Using this mapping, the L AAs long `th
subsequence χ(`; dm,L), `= 1, . . . , Nm, in Equation (2.1) can be represented by the
linear combination of L TF shifted Gaussian signals as
x`,m(t) =
L∑
l=1
g(t; l, u[{αl}]) =
L∑
l=1
gb(t− lT ) exp (j2pi u[{αl}]F t), (2.4)
on the domain t ∈ (` T − Tg, (`+ L)T + Tg).
Note that we denote x`,m(t) to be dependent onm to clarify that the mapped signal
originated from the mth peptide. This dependence is required for the estimation
algorithm since we need to track the MFI of the subsequence; both the peptide and
any of its generated subsequences have the same MFI. The function u[{αl}] in (2.4),
that replaced k in (2.3), is the integer-valued frequency shift that is used to map the
type of the lth AA. Figure 2.2 provides an example of the mapping for the subsequence
EEDFRV of length L= 6 AAs. Note, for example, that time shifts l= 1, 2, share the
same frequency shift, u[{α1}] =u[{α2}] = 14, since the type of AA (glutamic acid) is
the same for both positions in the subsequence. Using the mapping, the weighted
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Gaussian signal representation for the mth peptide Vm is given by
vm(t) =
Lm∑
i=1
g(t; i, u[{αi}]) =
Lm∑
i=1
gb(t− iT ) exp (j2pi u[{αi}]F t), (2.5)
where t ∈ (T − Tg, LmT + Tg) and Lm is the length of the peptide AA sequence,
m= 1, . . . ,M .
T 
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Figure 2.1: TF Representation of Mapping AA Type to Frequency Shifts
2.4 Peptide Subsequence Estimation Algorithm
Once the set SL of all unique subsequences of length L on a microarray are formed
as in (2.2), we need to find the OCRC of each subsequence; we use occurrence count
(OCRC) as a metric for the number of times each subsequence appears in the array.
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Figure 2.2: TF Representation of the Mapped AA Subsequence EEDFRV.
In addition to OCRC, we sometimes down-select the set of peptides used to find an
occurrence count, and denote this as the down-selected occurrence count (DS-OCRC).
In particular, we want to detect the signal x`,m(t) in (2.4) that represents the
`th subsequence χ(`; dm,L) of length L, `= 1, . . . , Nm, of the mth peptide within all
possible signals vm(t), m= 1, . . .M , that represent the M peptides. This process is
analogous to searching for similarity between a given subsequence and all the peptide
sequences on the microarray. Essentially, we use this approach to estimate pathogen
epitopes and identify candidate pathogen mimotopes.
We perform the subsequence estimation and identification method in TF using the
matching pursuit decomposition algorithm [102]. The matching pursuit decomposi-
tion (MPD) is an iterative signal expansion technique that can be used to represent
a signal with time-varying spectral characteristics as a linear combination of basis
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functions. Normally, the basis functions are selected from a dictionary that consists
of a basic Gaussian signal that is centered at the TF origin as well as time-shifted,
frequency-shifted and scaled transformed versions of this basic signal. Transformed
Gaussian signals form the dictionary as they highly-localized in the TF plane; how-
ever, based on the application, the MPD can give a sparse representation if the
dictionary is formed using real signals [103].
If the signal under processing is well-matched in TF to the Gaussian basis func-
tions, then the algorithm converges after only a few iterations; otherwise, the MPD
can be computationally intensive. For our application, the processing signals are per-
fectly matched to the Gaussian basis functions as we map the AAs in the peptide
sequences directly to Gaussian signals. We thus expect the MPD to converge fast
when used to identify subsequences, provided that the time shift and frequency shift
transformations of the MPD dictionary are selected to be integer multiples of the
time and frequency shift parameters T and F in Equation (2.3), respectively.
Algorithm 1 provides the steps of our proposed approach to determine the DS-
OCRC / OCRC of each unique subsequence χj, j= 1, . . . ,J , of length L, in a mi-
croarray. In order to compute both the DS-OCRC/OCRC of each subsequence as
well as keep track of the MFIs of the peptides that contributed to the count, we
compute the DS-OCRC/OCRC of the length-L `th unique subsequence χ(`; dm,L) of
the mth peptide, m= 1, . . . ,M . The subsequence is represented by the signal x`,m(t)
with duration (LT + 2Tg) and MFI dm. To reduce computational cost, we need to
ensure that we do not unnecessarily process two or more subsequences when their
corresponding mapped signals x`,m(t) and x`′,m′(t), m 6= m′ and any ` or `′, are iden-
tical; each subsequence to be processed is generated only once, because of how the
subsequences are defined in Equation (2.2). The algorithm computes inner products
between the linear combination of Gaussian signals in x`,m(t) that represent the `th
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subsequence and the linear combination of Gaussian signals vm(t) that represent the
mth peptide. A perfect match is determined only when the sum of the inner product
outputs is exactly equal to L. The DS-OCRC/OCRC of the `th subsequence is the
total number of perfect matches after processing all microarray peptides.
Algorithm 1 runs with the following considerations:
• Consider a sample microarray consisting of M random peptide sequences
• Either calculate the OCRC using m= 1, . . . ,M peptides, or calculate the DS-
OCRC using a down-selected peptide set of m= 1, . . . , Q, where Q ≤M
• Use the approach in Section 2.2 to generate the length-L unique subsequence
χj, j= 1, . . . ,J , from the set SL in Equation (2.2); equivalently, by ensuring
that each subsequence is not generated more than once when considering all
peptides, generate the length-L unique subsequence χ(`; dm,L), `= 1, . . . , Nm,
from the mth, length-Lm, peptide, m= 1, . . . ,M ; note that Nm ≤ (Lm−L+ 1)
and J ≤∑Mm=1Nm
• Form a one-to-one correspondence between the indexing of the unique subse-
quences: χj is equivalent to χ(`; dm,L), with j= 1, . . . ,J , `= 1, . . . , Nm, and
m= 1, . . . ,M
• Use the TF mapping in Section 2.3 to represent: (i) the mth peptide of length
Lm, m= 1, . . . ,M , by the signal vm(t) in Equation (2.5); and (ii) the `th sub-
subsequence χ(`; dm,L), `= 1, . . . , Nm, of length L and MFI dm, by the signal
x`,m(t) in Equation (2.4)
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Algorithm 1 Computation of OCRC Υj and Mean MFI d¯j of Unique Subsequence
χj in a Peptide Microarray
for m= 1, . . . ,M do
? Set count = 0 and d¯ = 0 to initialize the OCRC/DS-OCRC and the mean MFI
respectively of the `th unique subsequence of the mth peptide
? Form the MPD dictionary Dm = {g(t; 1, u[{α1}]), . . . , g(t;Lm, u[{αLm}])} using
the signals in (2.3)
? Denote any signal in the dictionary Dm by ym(t)
for n= 0, 1, . . . , (Nm − L + 1) {shift the subsequence by one AA position at a
time} do
• Initialize the MPD iterations by setting r(0,n)` (t) =x`,m(t− nT )
for ζ = 0, . . . ,L − 1 {perform L MPD iterations} do
 Compute C(ζ,n)`,Dm =
∫
r
(ζ,n)
` (t) y
∗
m(t) dt, the correlation of r
(ζ,n)
` (t) with every
dictionary signal
 Select the dictionary signal with the maximum correlation
y
(ζ,n)
` (t) = argmax
ym(t)∈Dm
C(ζ,n)`,Dm , t ∈
(
(n+ 1)T − Tg, (n+ L)T + Tg
)
(2.6)
 Compute the MPD coefficient λζ,n =
∫
r
(ζ,n)
` (t) y
∗ (ζ,n)
` (t) dt {if the two
AAs match, λζ,n = 1}
 Compute the residue r(ζ+1,n)` (t) = r(ζ,n)` (t)− λζ,n y(ζ,n)` (t)
end for
• Evaluate the sum of the MPD coefficients, Λm,n =
L−1∑
ζ=0
λζ,n
if Λm,n =L then
- Subsequence x`,m(t − nT ), with fluorescence value dm, is a perfect match
in peptide vm(t)
- Update the mean MFI of as d¯=
(
d¯·count + dm
)
/ (count + 1)
- Increase OCRC/DS-OCRC of subsequence x`,m(t) by one, count = count+1
end if
end for
end for
. Obtain the final OCRC/DS-OCRC as Υj = count
. Algorithm output: The OCRC/DS-OCRC and mean MFI of subsequence χj are
Υj and d¯, respectively
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2.5 Estimation of Subsequences with Single AA substitutions
Subsequences formed by replacing a single AA with another AA are called point
mutations or single AA substitutions. Although substituting one AA can signifi-
cantly change the peptide structure and binding characteristics, sometimes the effect
is unimportant to structure or binding. Silent mutations occur when the substitution
is by an AA with similar properties as the original AA, resulting in no significant
change in functionality [104]. As a result, single substitutions of AAs with similar
properties are important to consider for estimating specific types of subsequences
such as epitopes and mimotopes, or substitutions are in the epitope, but do not form
critical contacts with the antibody.
Algorithm 1 can be modified to estimate subsequences with single AA substitu-
tions at a time. In particular, the design of the proposed algorithm is inherently
matched to handle substitutions with computational ease. This is because the algo-
rithm only needs to find subsequence matches with identical mapped time shifts, as
they represent the position of an AA in the sequence; all frequency shifts are allow-
able as they represent the AA type. Note, however, that we need to keep track of
the exact AA substitution in order to determine the OCRC of a silent mutation. The
resulting approach for estimating silent mutations is described in Algorithm 2.
Algorithm 2 runs with the following considerations:
• Consider a sample microarray consisting of M random peptide sequences
• Either calculate the OCRC using m= 1, . . . ,M peptides, or calculate the DS-
OCRC using a down-selected peptide set of m= 1, . . . , Q,where Q ≤M
• Following Algorithm 1, generate the length-L unique subsequence χj, j= 1, . . . ,J ,
or equivalently χ(`; dm,L), `= 1, . . . , Nm, from the mth, length-Lm, peptide,
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m= 1, . . . ,M ; form a one-to-one correspondence between the subsequence in-
dexing
• Following Algorithm 1, use TF mapping to represent the mth peptide sequence
by vm(t) and the `th subsequence χ(`; dm,L) by x`,m(t) in (2.4)
2.6 Peptide Sequence Down-Selection and Bias-Normalization
Although the microarrays consist of a very large number of peptides, not all pep-
tides are applicable for detecting antibody subsequences that bind to specific antigens.
In order to avoid unnecessary processing, we down-select the peptides using two dif-
ferent schemes. The first scheme involves down-selecting peptides with high MFIs;
this is because only a small fraction of the peptides bind strongly and specifically
to the monoclonal antibody samples. The remaining peptides bind weakly and non-
specifically, and thus do not provide sufficient information on the sample antibodies.
Antibody peptides that bind specifically, but only somewhat strongly to antigens are
also not down-selected. To include these peptides, we use a second scheme which
involves the calculation of Pearson’s (PCC) that can be used to down-select peptides
that bind strongly on only one of the monoclonal antibody samples. The PCC is
calculated between a vector of MFIs and a reference vector, and it measures the sim-
ilarity between the two vectors. PCC of −1, 0, and 1 imply negative correlation, no
correlation, and positive correlation, respectively. For each of the M peptides in the
%th microarray sample, %= 1, . . . ,P , the PCC is calculated as
r%,m =
(
sm − s¯m 1P
)T(
b% − 1P 1P
)
(2.8)
for m= 1, . . . ,M . Here, sm = [s1,m . . . sP,m]T, s%,m is the mean MFI of the mth
peptide in the %th microarray sample, s¯m = (1/P)
∑P
%=1 s%,m is the MFI of all the
mth peptides in the P microarray samples, 1P is a P × 1 column vector of ones, b% is
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Algorithm 2 Computation of OCRC and Mean MFI of Subsequences With Single
AA Substitutions.
for m= 1, . . . ,M do
? Form the MPD dictionary using the signals in Equation (2.3)
{Ensure that any position on the sequence can be substituted at a time by any
of 16 possible AAs}
{Exclude AAs threonine, methionine, soleucine, and cysteine that are not used
in the 330k microarray; these AAs correspond to frequency shifts k= 4, 8, 11, 16,
respectively, in Equation (2.3)}
Dm = {g(t; i, 1), . . . , g(t; i, 3), g(t; i, 5), . . . , g(t; i, 7), g(t; i, 9),
g(t; i, 10), g(t; i, 12), . . . , g(t; i, 15) | i = 1, . . . , Lm}
? Denote any signal in the dictionary Dm by ym(t)
for n= 0, 1, . . . , (Nm − L + 1) {shift the subsequence by one AA position at a
time} do
for l = 1, . . . ,L {consider AA at the lth position of χ(`; dm,L)} do
for k= 1, 2, 3, 5, 6, 7, 9, 10, 12, 13, 14, 15 {substitute AA at the lth position
by the kth AA} do
• Generate the (l, k)th new subsequence ql,k,m(t− nT ) of x`,m(t− nT ) by
substituting the lth position of x`,m(t− nT ) by the kth AA
ql,k,`,m(t− nT ) = g(t− nT ; l, k) +
L∑
l′=1
l′ 6=l
g(t− nT ; l′, u[{αl′}]) (2.7)
• Set countl,k = 0 and d¯l,k = 0 to initialize the OCRC/DS-OCRC and
mean MFI of the (l, k)th subsequence
• Initialize the MPD iterations by setting r(0,n)` (t) = ql,k,`,m(t− nT )• Perform L iterations as in Algorithm 1 to obtain the MPD coefficients
λζ,n, ζ = 0, . . . ,L
• Compute the sum of the MPD coefficients, Λm,n =
L−1∑
ζ=0
λζ,n
if Λm,n =L then
- Mapped subsequence ql,k,`,m(t−nT ) that was derived from the mapped
subsequence x`,m(t − nT ), with MFI dm, is a perfect match in the
mapped peptide vm(t)
- Update the mean MFI of subsequence ql,k,`,m(t− nT ):
d¯l,k =
(
d¯l,k countl,k + dm
)
/ (countl,k + 1)
- Increase by one the OCRC of subsequence ql,k,`,m(t− nT ):
countl,k = countl,k + 1
end if
. Obtain the final OCRC as Υl,k,j = countl,k and the final mean MFI as
d¯l,k,j = d¯l,k
. Algorithm output: The OCRC and mean MFI of the subsequence formed
by substituting the lth position of χj by the kth AA are Υl,k,j and d¯l,k,j,
respectively
end for{kth for loop}
end for{lth for loop}
end for{nth for loop}
end for{mth for loop}
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a P ×1 reference vector that is defined as the %th column of a P ×P identity matrix,
and T denotes vector transpose. The reference vector indicates the correlation pattern
needed to match the %th array.
Down-selecting based on the PCC provides an effective ranking metric for various
cases, as illustrated in the following three examples. The first example assumes that
all P = 8 samples have approximately the same MFI. Such a situation can occur when
all samples are either binding non-specifically to something in the antibody or not
binding to anything. Using the reference vector b1 = [1 07] for the sample %= 1, the
PCC is computed as r1,m = 0.01 in (2.8), and 0% is a % × 1 vector of zeros. The
second example assumes a specific binding at the microarray for which the PCC is
computed. Specifically, as shown in Figure 2.3a, the MFI of the specific binding in the
%= 1 sample is higher than the values of the non-specific binding in the %= 2, . . . , 8
samples. Using reference vector b1, the PCC is r1,m = 0.98 for the %= 1 sample. In
the last example, the specific binding is for the %= 2 sample, as shown in Figure 2.3b;
using b1, the PCC for the d= 1 sample is r1,m =−0.22. Thus, the correlation for
the MFI in Figure 2.3a is very large as the binary vector matches the MFI pattern,
whereas the correlation for the MFI in Figure 2.3b is negative as the binary vector
does not match the pattern.
The PCC provides a better metric than MFI for ranking peptides with antigen
binding subsequences. The binding to an epitope different than the original epitope
can be equal to the the original binding. If that occurs, peptides with larger MFI
on the sample of interest, relative to the same peptide on other samples, will be
kept because of that specific binding. This is demonstrated for the monoclonal Ab8 in
Figure 2.4. Using the PCC instead of MFI to rank peptides resulted in a larger fraction
of peptides with epitopes. This behavior was typical for most of the monoclonal
samples. In the few cases where MFI ranking resulted in a higher percentage of the
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Figure 2.3: The MFIs in (a) and (b) Are Due to a Specific Binding for the First and
Second Monoclonal Antibody Samples, Respectively, and Non-Specific Binding for
All Other Samples.
selected peptides containing epitopes, the PCC also performed well in estimating the
epitope. Note that when we used the MFI as the ranking metric for monoclonal Ab8,
the epitope was not correctly estimated.
In some cases, it was found that the subsequence estimation performance in-
creased when the MFIs of the down-selected peptides were normalized. The normal-
ization tends to remove biases in the data resulting from inter-experimental varia-
tion (wafer-to-wafer-synthesis variation, temperature, duration, mechanical forces) or
intra-experimental variation (sub-wafer variation, peptide location effects). The nor-
malization approaches used include logarithmic (log10) normalization (resulting in
Gaussian-like characteristics), median normalization, and linear model normalization
[40, 105]. The effect of normalization is demonstrated in Figure 2.4 for monoclonal
mAb8. For example, logarithmic normalization of the MFIs before computing the PCC
resulted in more peptides with subsequences than combined logarithmic and median
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normalizations. Note, however, that the best estimation results were obtained when
the MFIs were not normalized, indicating that the data are of consistent quality.
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Figure 2.4: Fraction of Peptides With Epitopes for Different Numbers of Down-
Selected Peptides for Monoclonal Antibody Ab8.
2.7 Subsequence Estimation Results
The analysis data consisted of 330k peptide microarrays for eight monoclonal an-
tibody samples and a list of the synthesized peptides. The peptides are the same for
all eight samples, allowing for comparison calculations across different samples for the
same peptide. Algorithms 1 and 2 provide the steps for estimating epitopes and iden-
tifying mimotopes based on finding unique subsequences and their DS-OCRC. The
most frequently occurring subsequences in the down-selected peptides are selected as
the estimated epitopes. The algorithms also provide a list of additional subsequences
that, although they do not occur as frequently as the epitope estimates, they still
occur a sufficiently large number of times to warrant further investigation. These
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subsequences are proposed as potential antigen mimotopes as they appear to have
readily permissible substitutions of the true epitopes.
2.7.1 Epitope Estimation Performance Results
We used the algorithms to estimate epitopes for the eight monoclonal samples
as the most frequently occurring subsequences. The resulting estimated epitopes
are listed in Table 2.1, together with their OCRC, DS-OCRC and mean MFI. As
demonstrated in the table, the algorithms estimated exact subsequences for the full
epitopes of the monoclonal antibodies 2C11, A10, Ab1, Ab8, and DM1A; close matches
were obtained for 4C1, Flag, and HA. These results demonstrate both the diversity
of the peptides on the microarray, spanning enough of the possible sequence space to
bind all eight monoclonal antibodies, as well as the high performance of the epitope
estimation algorithm in finding relevant epitopes.
Sample Full Estimated Mean
mAb Epitope Epitope OCRC DS-OCRC MFI
2C11 NAHYYVFFEEQE VFFEEQE 22 7 805
4C1 LQAFDSHYDY GYDSR 21 13 8,731
A10 EEDFRV EDFRV 34 20 65,535
Ab1 NTFFRHSVVV RHSVV 209 186 65,535
Ab8 TFSDLWKLLPE DLWKL 63 6 1,174
DM1A AALEKDYEEVGV AALEKD 2,053 5 2,368
Flag DYKDDDDK AALEKDG 2,001 1,323 44,567
HA YPYDVPDYA YDAPE 16 14 61,414
Table 2.1: Epitope Estimates With OCRC, DS-OCRC, and the Mean MFI for Those
Estimates.
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The performance of the epitope estimation algorithm is tightly coupled to the
frequentness and diversity of the subsequences in a microarray. By frequentness we
mean how often a specific subsequence (of fixed length) occurs in the whole microar-
ray; this is important because it affects the number of peptides the antibodies bind on
and, as a result of that, the number of down-selected peptides that contain an epitope
subsequence increases, and those subsequences are at the top of the DS-OCRC those
peptides; and by diversity we mean the variety of peptide subsequences included in
the whole microarray. We present next the processing of specific subsequences for
four of the eight monoclonal antibody epitopes. For Ab1, we estimated the exact epi-
tope whereas for 4C1, Flag, and HA, we obtained comparable (not exact but similar)
epitopes. Comparable and not exact epitopes are estimated because the true epitopes
have low OCRC on the microarray and also the subsequences estimated have only
moderately strong binding strength.
2.7.2 Epitope Estimation Analysis
As the microarray peptides are typically much longer than the estimated epitopes,
the monoclonal antibodies only bind to a fractional portion of a peptide. It is thus
only possible to infer that a particular subsequence contributed to the binding if that
subsequence is present on multiple peptides with large MFIs. The success of the
estimation algorithm also depends on the diversity of the microarray peptides; this
is achieved using the sufficiently large 330k random sequence peptide microarray. In
particular, many of the shorter length subsequences were found to repeat numerous
times. As a result, this increased the robustness of the estimation algorithm and also
allowed for an analysis of single AA substitutions based on binding strength.
In order to determine how well subsequences of different lengths are represented,
we list the number of potential subsequences on the microarray in Table 2.2. On
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Subsequence # of unique # of possible % of unique
length subsequences subsequences subsequences
4 58,700 65,500 89.5%
5 550,000 1,050,000 48.1%
6 1,490,000 1,680,000 9%
7 1,880,000 2,680,000 0.7%
Table 2.2: Number of Possible and Unique Subsequences of Varying Lengths on the
Microarray.
the 330k peptide microarray, approximately 90% of length-4 (and 50% of length-5)
subsequences occur on the array. Also, many of these subsequences are repeated
multiple times, as shown in Table 2.3. As it can be observed, most of the length-
4 and length-5 subsequences of the monoclonal epitopes are present on the array
and are also repeated multiple times. This occurs for the epitopes of monoclonal
antibody samples 2C11, A10, Ab1, and Ab8 and DM1A, for which we obtain exact
epitope estimates. The results for the remaining three monoclonal antibody samples,
4C1, Flag, and HA did not provide exact matches to the full epitopes. It is important to
emphasize that the performance of the proposed estimation algorithm depends on the
design of the random peptides on the microarray. More specifically, the performance
depends on how frequently subsequences of the full epitope occur, whether the actual
subsequences are present, and how strongly the antibodies bind to the peptides with
these subsequences. As it is not possible to provide the details of every selected
epitope, we illustrate next some specific examples which show trends in the data.
Our analysis demonstrated that it is possible that the full epitope does not cor-
respond to the subsequence with the highest binding strength. This is demonstrated
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Subsequence % of subsequences repeated at least G times
Length G= 5 G= 10 G= 50 G= 100 G= 500 G= 1, 000
4 99.8% 99.5% 95.2% 90% 69.1% 46.1%
5 94.2% 89.2% 61.5% 38.6% 1.2% 0.3%
6 57.8% 37% 2.6% 0.4% 0.2% 0.2%
7 5.9% 1.2% 0.2% 0.2% 0.1% 0.1%
Table 2.3: Percentage of Subsequences of Varying Lengths That Are Repeated in the
Microarray at Least G Times.
with the monoclonal antibody sample Ab1, with full epitope NTFFRHSVVV. Table 2.4
lists the matched subsequences, their OCRC and corresponding mean MFIs for Ab1.
Although the AA T occurs in the full epitope, we do not consider this AA in our
estimation as it was not used to generate the peptides [101]. Also, when computing
the OCRC of a short subsequence whose identical AA pattern appears in a longer
subsequence, we do not include the OCRC of the longer subsequences. For example,
when computing the OCRC of HSVV, we did not include the peptides which con-
tain RHSVV, RHSVVV or any other higher-length subsequences of NTFFRHSVVV. This is
because we wanted to ensure that the OCRC metric for HSVV is not influenced by
the binding strength of longer subsequences. From Table 2.4, we can conclude that
while RHSVV has the highest binding strength, the smaller length HSVV also has a
high binding strength when compared to other subsequences. No conclusions can be
made from the single occurrence of RHSVVV because some variability exists in the MFI
measurements, and because multiple subsequence occurrences are required to disam-
biguate which subsequence on a peptide caused the antibody binding. Also, longer
subsequences such as FFRHS, FRHSV, and HSVVV have very low binding strength.
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The estimation results for Ab1 are typical for other samples in that not all sub-
subsequences of the epitope bind strongly to the antibody. Typically, the longest
subsequence was estimated and listed in Table 2.1, and this often corresponded to
the most dominant subsequence, that is, the subsequence with the highest binding
strength. For Ab1, the dominant subsequence is RHSVV (shaded in Table 2.4). Note,
however, that not only RHSVV but also HSVV occurred more frequently than the other
length-4 and length-5 epitopes. However, RHSVV has comparatively larger binding
strength.
Ab1 Mean
subsequence OCRC MFI
L= 4
FFRH 44 1,394
FRHS 28 2,711
RHSV 87 3,119
HSVV 402 11,455
SVVV 5 1,087
L= 5
FFRHS 4 2,250
FRHSV 2 1,308
RHSVV 208 65,535
HSVVV 7 2,062
L= 6
RHSVVV 1 10,502
Table 2.4: Subsequences of Varying Lengths L for Ab1 Where the Shaded Row Cor-
responds to the Estimated Epitope.
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The exact epitope was not estimated for the monoclonal antibody HA. The full
epitope of this monoclonal is YPYDVPDYA; however, the estimated epitope YDAPE ap-
pears to be a substitution (at positions 3 and 5) of the exact epitope YDVPD. We thus
selected this non-exact epitope as our estimate since the exact subsequence occurred
very infrequently on the array. Tables 2.5a and 2.5b show the occurrences of different
epitope subsequences and the mean MFIs for the antibody epitope subsequence YDVPD
and the estimated epitope sequence YDAPE, respectively. While the antibody epitope
sequence YDVPD occurred on the array with a high binding strength, the estimated
epitope subsequence YDAPE occurred more frequently, and with almost as high bind-
ing strength. The exact epitope was also not estimated for the monoclonal antibody
Flag. The non-exact estimate for Flag was AALEKDG, which is interesting because it
is a close match to the true epitope for monoclonal antibody DM1A of AALEKD. The
similarity of the estimated epitope for Flag, and the true epitope of DM1A is due to
the similarities between their true epitopes, and the sparsity of sufficiently long true
epitope subsequence for Flag. The important overlap between these two epitopes is
the KD AA pair, and the permissive binding of Flag antibodies.
The sparsity of true epitope subsequences of Flag on the array is seen in Table
2.17, which lists the median MFI and the OCRC for each of the subsequences for this
monoclonal antibody. The only true epitope subsequence with high binding strength
was DYKDD; however, this subsequence only occurred twice on the array, which is not
very frequently for a 5-mer, and therefore it is hard to identify it as an important
subsequence. The overlap between the epitopes of the monoclonal antibodies Flag
and DM1A is the AA pair KD. The MFI effects of this overlap can be seen by comparing
the MFIs of peptides which contain subsequences similar to the epitopes. Figures 2.5
and 2.6) provide scatter plots of the MFIs for all the peptides on the array that contain
a 4-mer or longer subsequence of peptide AALEKD, the estimated epitope for DM1A. In
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Figure 2.5, the MFIs of HA are plotted with respect to the MFIs of Flag. As expected,
the MFIs for HA are small as this sample has the unrelated true epitope YPYDVPDYA.
This is in contrast to the scatter plot of Figure 2.6 which plots the MFIs of DM1A
versus Flag, which have related epitopes and therefore the peptides containing these
subsequences are bound strongly.
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Figure 2.5: Scatter Plots of the Fluorescence of Flag Compared to the MFI of HA.
Here, we list out the top DS-OCRC results for monoclonal antibody samples
2C11, A10, and HA in Tables 2.6 - 2.14 to show what subsequence occur beyond the
top estimate, what happens across multiple estimate lengths, and the characteristics
of the potential mimotopes which occur in these lists.
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Figure 2.6: Scatter Plots of the Fluorescence of Flag Compared to the MFI of DM1A.
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HA Mean
subsequence OCRC MFI
L= 4
YDAP 75 5,028
DAPE 98 884
L= 5
YDAPE 16 61,414
(a)
HA Mean
subsequence OCRC MFI
L= 4
YPYD 22 813
PYDV 18 688
YDVP 42 3,377
DVPD 28 21,429
VPDY 19 746
PDYA 462 757
L= 5
YPYDV 0 -
PYDVP 1 31,435
YDVPD 3 65,535
DVPDY 1 65,535
VPDYA 0 -
L= 6
YPYDVP 0 -
PYDVPD 1 65,535
YDVPDY 0 -
DVPDYA 0 -
(b)
Table 2.5: Subsequences of Varying Lengths L for (a) the Estimated Epitope of HA,
and (b) the True Epitope of HA. Note That in (a) the Shaded Row Corresponds to the
Estimated Epitope, and That in (b) the L = 5 and L = 6 True Epitope Subsequence
Do Not Occur Often on the Array.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FEEQE 168 7 586 5,826
FFEEQ 117 7 636 5,826
VFFEE 87 7 676 5,826
ARWFN 54 6 931 65,535
AVNWF 64 6 760 187
PWFNK 139 6 848 2,144
WFNRL 30 6 1,010 1,704
ARLRP 120 5 1,098 4,613
ARRVR 30 5 1,980 4,142
DARWF 37 5 834 65,535
Table 2.6: Estimated Top 10 Subsequences of Length L = 5 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FFEEQE 116 7 636 5,826
VFFEEQ 86 7 685 5,826
DARWFN 10 4 1,197 65,535
AWRGFN 7 3 997 1,692
FARLRE 9 3 1,183 3,327
FKYARL 24 3 1,208 2,414
HFFKAL 6 3 954 1,693
KARLRP 6 3 1,652 4,613
WFARLL 6 3 1,050 1,769
WFNGYA 12 3 938 1,470
Table 2.7: Estimated Top 10 Subsequences of Length L = 6 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
VFFEEQE 85 7 694 5,826
YVFFEEQ 22 3 805 2,089
AALEKDG 2,000 2 630 16,310
ALEKDGY 111 2 701 16,310
AVARPFQ 2 2 1,849 2,182
AVGWQAR 3 2 1,922 16,130
AWRGFNY 3 2 997 1,616
FARLREY 2 2 1,415 1,647
FEEQERY 13 2 656 1,559
FFEEQER 23 2 759 1,559
Table 2.8: Estimated Top 10 Subsequences of Length L = 7 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
WDVA 272 55 17,534 65,535
DVAW 473 52 8,790 65,535
DSAW 442 46 8,763 65,535
WQEA 135 46 65,535 65,535
DAAW 385 40 11,101 65,535
DVSW 239 36 19,765 65,535
QEYA 323 35 37,316 65,535
EDVA 242 34 20,428 65,535
WFEA 267 34 8,875 65,535
EWDA 346 32 10,617 65,535
Table 2.9: Estimated Top 10 Subsequences of Length L = 4 Obtained When Algo-
rithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
EDFRV 34 20 65,535 65,535
EWDVA 41 15 65,535 65,535
EDVAW 35 14 65,535 65,535
WFEGA 53 14 32,589 65,535
WDVAP 33 13 65,535 65,535
DAAWP 52 11 16,042 65,535
DVAWG 57 11 10,288 65,535
EWDAA 44 11 31,044 65,535
PWFEA 69 11 10,370 65,535
WDVAW 42 11 19,322 65,535
Table 2.10: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
In Tables 2.6 - 2.14 the most frequently occurring down-selected subsequences for
lengths L = 7, L = 5, and L = 5 respectively are the epitope estimates. While
Algorithm 1 can be run for different length subsequences, we choose the longest,
consistent top subsequence as the epitope estimate. For example, the top subsequence
in Table B.4 is VFFEEQE. We see that the top few estimates in Tables 2.7 and 2.6 are
all subsequence of VFFEEQE, e.g. FEEQE, FFEEQ, VFFEE, FFEEQE, and VFFEEQ. These
top subsequence infer that the there is a longer length epitope subsequence. Similarly
for HA and the top subsequence in Table 2.13 is YDAPE, and the top two subsequence
in Table 2.12 are YDAP and DAPE.
While this sort of trend is seen in many of the monoclonal samples, sometimes the
binding strength appears to be dependent on a more complete epitope. An example
of this is seen for A10 in Table 2.10, where the top L = 5 subsequence is the epitope
estimate. Neither EDFR or DFRV are seen in the Table 2.9 L = 4 subsequences, however
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
DFRVDW 22 8 35,188 65,535
FRVDWK 40 8 5,252 65,535
EDFRVD 6 5 65,535 65,535
EDVRPF 10 5 39,784 65,535
PWQEAS 7 5 65,535 65,535
AVWFEG 11 4 7,222 65,535
DVAWPF 12 4 22,508 65,535
EDARSG 6 4 34,672 65,535
EDVAPN 9 4 60,074 65,535
EDVAWP 6 4 65,535 65,535
Table 2.11: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
DFRV, DFRV, and FRV are present in the top three L = 6 subsequences in Table 2.11.
One of these two methods is used to determine which length subsequence should be
the epitope estimate for each of the eight monoclonal antibodies.
Tables 2.6 - 2.14 also contain information about the potential mimotopes for those
three monoclonal antibodies. The potential mimotope for 2C11 is DARWFN. It meets
the four criteria listed for mimotopes, and some of its subsequences, ARWFN, ARWF,
and WFN are seen in the L = 5 subsequence in Table 2.6. Similarly, the potential
mimotopes for A10 and HA meet the criteria for mimotopes, and subsequences of
these mimotopes are seen in the top DS-OCRC lists of smaller lengths.
In addition to the results listed in Tables 2.6 - 2.14, we include a full list of
Algorithm 1 results in Appendix B. We list the top 10 epitope estimates, ranked in
descending order by DS-OCRC, for all eight mAbs, and L = 4, 5, 6, and 7.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
YDAP 91 44 6,400 65,535
DAPE 114 31 1,537 65,535
ADAP 285 27 864 65,535
DVPE 93 25 1,008 65,535
DAPG 168 24 1,122 65,535
DVPD 33 24 31,506 65,535
DAPV 112 23 1,027 65,535
YDVP 47 23 4,846 65,535
LDVP 153 20 823 65,535
FDAP 47 18 2,071 65,535
Table 2.12: Estimated Top 10 Subsequences of Length L = 4 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
YDAPE 16 14 61,414 65,535
PYDAP 11 10 44,289 65,535
YDSPE 13 9 12,542 65,535
FDAPV 12 8 9,961 56,901
PFDAP 8 8 47,053 65,535
QYDAP 10 8 31,196 65,535
YDVPE 9 8 51,759 65,535
ADAPE 18 7 10,457 65,535
EDLPD 15 7 1,706 11,385
FYDAP 11 7 5,583 65,535
Table 2.13: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FNYDSP 6 4 2,146 65,535
GYDAPE 4 4 59,422 65,535
NQYDAP 4 4 47,437 65,535
NYDSPE 4 4 11,997 65,535
AALEKD 2,053 3 694 11,285
ALEKDG 2,002 3 697 11,285
APYDAP 3 3 44,289 65,535
EDHPDG 3 3 4,984 40,563
EDLPDS 4 3 6,698 11,385
FFYDAP 3 3 6,135 65,535
Table 2.14: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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2.8 Substitution Analysis
The epitope estimates are derived from the peptides on the array which contain
that epitope subsequence. In addition to that specific subsequence, there are other
peptides on the array which contain that same subsequence, but with a single AA
substitution. Our proposed algorithm for detecting subsequences using single AA
substitutions is provided in Algorithm 2. Using this algorithm, we can analyze how
these single AA substitutions affect the binding strength. In doing this, we see that
the binding is not exact, but that some of the AAs in the epitopes can be substi-
tuted without much of a loss in binding strength; in some cases, these substitutions
increase the binding strength. However, there are also specific AAs in the epitope
subsequence which are required for the binding, and substituting them with different
AAs can dramatically decrease the binding strength. One example of this is seen in
Tables 2.15a and 2.15b which show AA substitutions at positions which are tolerant
of substitutions and intolerant of substitutions, respectively. Figures 2.7a and 2.7a
are plots of the MFI listed in the tables; the plots clearly show how much more toler-
ant of substitutions 4C1 is for epitopes in the first AA of the subsequence YDS than
it is for substitutions in the third AA of the subsequence GY S. The tolerance for AA
substitutions is particularly helpful when trying to estimate an epitope whose exact
subsequences do not appear frequently on the array. This is true for Flag, where the
third AA of the exact subsequence KDDD is substituted to form subsequence KDGD; this
subsequence appears more frequently on the microarray.
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(a) MFIs for YDS substitutions
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(b) MFIs for GY S substitutions
Figure 2.7: The Mean MFIs for Two Different Substitutions of GYDS: (a) Substitu-
tion YDS is Tolerant of Substitutions; and (b) Substitution GY S is Not Tolerant of
Substitutions.
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Mean
AA OCRC MFI
A 11 1,457
R 19 982
N 100 977
D 6 3,792
Q 85 1,776
E 129 4,337
G 158 3,667
H 201 1,337
L 5 693
K 67 1,119
F 107 883
P 55 2,503
S 9 1,624
W 50 1,194
Y 6 844
V 16 855
(a)
Mean
AA OCRC MFI
A 267 803
R 195 1,011
N 26 947
D 158 3,667
Q 13 873
E 21 805
G 6 867
H 20 784
L 165 784
K 42 859
F 13 775
P 47 837
S 21 813
W 16 856
Y 9 780
V 37 751
(b)
Table 2.15: AA Substitutions With OCRC and Mean MFI for (a) GY S and (b) YDS.
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2.8.1 Mimotope Identification
In addition to showing the top epitope results for all eight monoclonal antibodies,
we show expanded results for monoclonal antibodies 2C11, A10, and HA in Tables 2.6
- 2.14. These results in these tables are listed in descending order by DS-OCRC.
The most frequently occurring subsequence according to the DS-OCRC, and the
subsequences can be used to find mimotope sequences.
Sample Full Potential
mAb Epitope Mimotope
2C11 NAHYYVFFEEQE DARWFN
4C1 LQAFDSHYDY ADSWP
A10 EEDFRV EWDVA
Ab1 NTFFRHSVVV -
Ab8 TFSDLWKLLPE -
DM1A AALEKDYEEVGV -
Flag DYKDDDDK ALEKDGD
HA YPYDVPDYA EDLPD
Table 2.16: Potential Mimotopes for the Monoclonal Antibody Samples.
In addition to finding the monoclonal antibody epitopes, we used the algorithms to
identify potential mimotopes for the monoclonal antibody samples, as listed in Table
2.16. While these mimotopes do not match the AA subsequences of the full epi-
topes, they can potentially act as subsequences that uniquely bind to the monoclonal
antibodies, without matching the AA composition of the epitope. We deduced the
following considerations for potential mimotopes when analyzing random-sequence
peptide microarrays: mimotopes are (i) distinctively different from the epitope of a
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specific monoclonal antibody sample; (ii) distinct across all eight monoclonal anti-
body samples; (iii) notably different from other peptide subsequences when comparing
binding strength and/or occurrence count. From these considerations, we developed
the following criteria to identify potential mimotopes. A potential mimotope of a
monoclonal antibody sample is a subsequence that:
1. is not an exact or a single substitution match to a full or an estimated mono-
clonal epitope
2. is not sufficiently similar to high occurring peptide subsequences of other mon-
oclonal antibody samples
3. has a sufficiently large MFI
4. has a large DS-OCRC, obtained using the down-selected monoclonal peptides.
Following these criteria led to potential mimotopes for the monoclonal antibodies
samples 2C11, 4C1, A10, Flag, and HA. Subsequences of the remaining three mon-
oclonal antibody samples did not meet all of the aforementioned criteria, and thus
they were not identified as potential mimotopes.
The proposed approach identified some potential mimotopes, as listed in Table
2.18, for five of the monoclonal antibody samples we analyzed. As discussed in Sec-
tion 2.7, we provide some criteria we developed on mAb mimotope identification.
Although our mimotope analysis is only theoretical, we found that our criteria seem
to match mimotope identification approaches in recent publications. More specifically,
in [48], mimotopes were identified from peptide sequences by T cells with common
receptors as they resulted in increased antigen immunity. As the authors discuss, op-
timizing the identification of mimotopes can lead to improvements in antigen-specific
vaccines. Mimotopes were identified for a monoclonal cancer antibody using phage
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display efficient screening of random peptide libraries [46]. Similar to our findings, the
mimotopes were selected based on their strong binding to the original peptides; it was
also noted that stronger binding was obtained with AA substitutions. In [106], mi-
motopes displaying phages for monoclonal antibodies were investigated for biomarker
assay development; it was found that the diversity of mimotope displaying phages of
selected peptides is inversely correlated with binding strength.
Table 2.18 provides additional information on how we identified the mimotopes
for the five monoclonal antibodies in Table 2.18. For each monoclonal antibody, the
four criteria in Section 2.7 are met. In particular, all these mimotope subsequences
have very large median or maximum fluorescence intensities.
Flag Mean
sample OCRC FMI
L= 4
DYKD 16 947
YKDD 9 799
KDDD 2 523
DDDK 90 391
L= 5
DYKDD 2 23,744
DDDDK 22 376
Table 2.17: Subsequences of Varying Length L for Flag.
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Sample Full Potential Mean Max.
mAb Epitope Mimotope OCRC DS-OCRC MFI MFI
2C11 NAHYYVFFEEQE DARWFN 10 4 1,197 65,535
4C1 LQAFDSHYDY ADSWP 20 10 12,769 65,535
A10 EEDFRV EWDVA 41 15 65,535 65,535
Flag DYKDDDDK ALEKDGD 267 250 65,535 65,535
HA YPYDVPDYA EDLPD 15 7 1,706 11,385
Table 2.18: Identified Mimotopes for Five Monoclonal Antibody Samples With Cor-
responding OCRC, DS-OCRC Mean and Maximum Fluorescence Intensity.
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2.9 Peptide Array Data Consistency Analysis
In the previous sections of this chapter, we have shown how the exact and sin-
gle substitution matching algorithms can be used to successfully estimate epitopes,
discover mimotopes, and analyze the effects of amino acid substitutions on binding
strength. The epitope estimate results match closely with exact epitope subsequences,
showing that the algorithms are performing well, and that the data are consistent
enough to use PCC as a down-selection method. Using PCC instead of fluorescence
as the ranking metric improved the epitope estimation accuracy, and further perfor-
mance improvements could be expected with an improvement in consistency between
the data. This section compares the peptide array datasets for similarity using sta-
tistical characterizations of the fluorescing peptides and the adjacent background
substrate.
2.10 Data Collection
At the device level, after preparing and incubating the primary and secondary
antibodies onto the array, the array is washed and dried, and then illuminated with
fluorescent light. A 16-bit tagged image file format (TIFF) image of the fluorescing
array is recorded. This image is calibrated to be able to spatially locate pixels either
within the bounds of the peptide cluster, our outside of it. 12 pixels from within the
peptide cluster are median averaged to obtain the MFI, while 104 pixels from outside
of the peptide cluster are median averaged to obtain the median background intensity
(MBI). In addition to the MFI and MBI, the the standard deviation of the fluorescence
intensity (SFI) is calculated. These three quantities are the basis for analyzing the
quality of individual peptide array sample datasets, as well as the consistency between
them. Figure 2.8 is an illustration of the extent of the pixles (black squares) and the
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circular extent of the peptide cluster (blue circle). Pixels that lie entirely within
the circular extent of the peptide cluster are used for calculating the MFI and SFI,
while pixels entirely outside of the peptide cluster are used for calcuating MBI. Note
that the source image is 16-bit, and therefore the individual pixel intensity values are
between 0 and 65535, as are the MFI and MBI.
Figure 2.8: Image Pixels Inside of the Peptide Cluster Are Used to Estimate Statistics
Related to the Fluorescence, and Pixels Outside of the Peptide Cluster Are Used to
Estimate Statistics Related to the Background.
The eight monoclonal antibodies were collected at two different times. Five of
the eight monoclonal antibody array samples 2C11, 4C1, A10, Flag, and HA were
collected in January 2013, while the other three were samples, Ab1, Ab8, and DM1A
were collected in June 2012.
2.11 Dataset Analysis
One common method for comparing peptide array datasets is to compute the
Pearson’s correlation coefficient between the fluorescence values of two entire arrays.
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This scalar value is a good first order approximation of similarity, because we expect
that most of the peptides on the array will not be specifically bound to, that these
background peptides will for the most part be the same when comparing two different
monoclonal antibody samples.
Data normalization techniques seek to undo some of the biases and scalings that
can occur when data are not collected using identical procedures. As was discussed
previously, datasets can either be normalized through dividing the fluorescence values
by the median fluorescence value so that all datasets have a median fluorescence value
of 1, or by base 10 logarithmically transforming the datasets so that the distributions
are more “Gaussian-like”. When computing the Pearson’s correlation coefficient be-
tween array samples, median normalization does not affect the correlation coefficient
because part of that computation is to subtract out the mean array fluorescence. A
color-scaled matrix of the correlation coefficients between array samples with no nor-
malization and median normalization are shown in Figures 2.9a and 2.9b respectively.
Note that the data set order has been rearranged such that samples from the same
year are grouped together, i.e. the first five samples were collected in 2013, while
the last three samples were collected in 2012. Note that the correlation between two
samples is associative; the correlation between any two samples is the same regardless
of order.
From the correlation analysis, we can see that the data from 2012 is well corre-
lated independent of the normalization used, while the data from 2013 is a far less
correlated. A correlation value greater than 0.9 would indicate that the data were
collected using the same procedure, and that the non-specific binding between arrays
is consistent. The logarithmic transformation significantly improves the correlation
between most of the samples from 2013, with the exception of monoclonal antibody
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(b) Logarithmic transformation
Figure 2.9: Array Sample Correlations for (a) Unnormalized Data, and (b) Logarith-
mically Transformed Data
A10. While additional normalization techniques do exist, they would require more
calibration information than was available for this dataset.
Some of the array samples are very much uncorrelated (0.2-0.4), in apparent con-
tradiction to the results shown earlier in this chapter. However, lower array-to-array
correlation values and good estimation results are possible because the array-to-array
correlation is an aggregate metric for all 330k peptides, while only 2.5k peptides,
selected using the PCC ranking metric, are used to estimate the epitope. Improving
the array-to-array correlation is likely to result in a set of peptides which is more
likely to contain epitope subsequences.
As the individual pixel intensities are not provided in the peptide array data files,
we work with the statistical estimates which are provided such as the MFI, MBI, and
SFI. Mean estimates of the pixel intensity are also given, and from comparing the
mean to the median fluorescence intensity we see only small differences, and therefore
are able to conclude that the pixel intensity distributions are symmetric, and without
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additional information assume that they are mostly Gaussian. Thus, we look at the
ratio of the MFI to the SFI as a measure of data quality, and also look at histograms
of the MFI and MBI to see how they vary across peptide array sample.
Figure 2.10 is a plot of the MFI divided by the SFI. Because we assume an
underlying Gaussian distribution, this quantity is an approximation for a quality
factor. The median values of this distribution range between 5 and 9, showing that
the measurements themselves are much larger than the statistical variation of that
measurement. Additionally, we can see that the data again separates itself into two
groups, where the data collected in 2012 and the mAb A10 are in one group, and the
remaining data collected in 2013 are in the second group. Based on this data quality
metric, the data collected in 2013 (excluding A10) is higher quality data.
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Figure 2.10: Histograms of the Median Fluorescence Intensity Divided by the Stan-
dard Deviation of the Fluorescence Intensity Pixels.
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Figures 2.11 and 2.12 are histograms of the MFI and MBI respectively, for each
of the eight monoclonal antibody samples. From these two plots we see the same
groupings from previous figures. From these figures we can infer that the higher
quality factors for the 2013 data group (excluding A10) seen in Figure 2.10 was a
result of smaller SFI, as well as the relative size of MFI to SFI.
0 500 1000 1500 2000
0
1
2
3
4
5
6
7
8 x 10
4
Median Fluorescence Intensity
Co
un
t
 
 
2C11
4c1
A10
ab1
ab8
dm1a
flag
HA
Figure 2.11: Histograms of the Median Fluorescence Intensity for All Eight Mono-
clonal Antibodies.
The analysis in this section has shown that the monoclonal antibody data collected
in 2013 is, for the most part, of higher quality than the 2012 data. This is, according
to the scientists collecting the data a result of improved data collection practices,
including a higher level of consistency between samples. We can assume that if
the mAb data were collected again, that the epitope estimates would be at least as
accurate as they were with this data set.
58
0 500 1000 1500 2000
0
2
4
6
8
10
12
14 x 10
4
Median Background Intensity
Co
un
t
 
 
2C11
4c1
A10
ab1
ab8
dm1a
flag
HA
Figure 2.12: Histograms of the Median Background Intensity for All Eight Monoclonal
Antibodies.
2.12 Comparison Methods
Random sequence peptide arrays containing hundreds of thousands of peptides
are very new, and as a result, there are very few algorithms to which our epitope
estimation algorithms can be compared. The most directly comparable method is a
motif estimation algorithm [2] developed by the Center for Innovations in Medicine
[101]. This method analyzes the peptide array data and searches for subsequences
of length 3-7 which occur more than three times with MFI values that are statisti-
cally significant. They assess statistical significance by comparing the fluorescence
of peptides which contain the subsequence of interest to the fluorescence of peptides
selected at random from the array. Table 2.19 is a comparison of our results and the
results from Figure 1 of [2].
The two methods find approximately the same epitope sequences for five of the
eight monoclonal antibodies, however our method finds epitope subsequences for 2C11,
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A10, and Ab8 at the top of our epitope estimate lists, while their method does not find
an epitope subsequence for 2C11, and only finds epitope subsequences for A10, and
Ab8 in their 11th and 13th spots in their epitope estimate list. As they state in their
paper, these are difficult antibodies to estimate epitopes for because the antibodies
bind non-specifically to a range of peptide sequences with the same strength as the
specific binding. The reason we are able to estimate these epitopes is because we use
the PCC instead of fluorescence. As we showed in Figure 2.4 for Ab8, using correlation
as a ranking metric results in more peptides containing the epitope subsequences, and
this is true for 2C11, and A10 as well.
Sample Full Estimated Comparison Motif
mAb Epitope Epitope Epitope Rank
2C11 NAHYYVFFEEQE VFFEEQE - -
4C1 LQAFDSHYDY GYDSR DSFDS 1
A10 EEDFRV EDFRV EDF 11
Ab1 NTFFRHSVVV RHSVV RHSVV 1
Ab8 TFSDLWKLLPE DLWKL SDLKW 13
DM1A AALEKDYEEVGV AALEKD LEKD 1
Flag DYKDDDDK AALEKDG DY D 1
HA YPYDVPDYA YDAPE DVPD, YDAPD 1
Table 2.19: A comparison of Our Epitope Estimates to the Motif Estimates in [2].
60
Chapter 3
ALIGNMENT OF MULTIPLE PROTEIN ATTRIBUTES USING WAVEFORM
MAPPING
3.1 Protein Alignment and Generalization of Amino Acid to Waveform Mapping
Protein alignment methods find similarities in the structure and functional or evo-
lutionary attributes of the proteins being compared. Aligning proteins is important
for the discovery of evolutionary relationships, as well as discovery of important drug
target locations, and for finding the effects of gene mutations. When aligning, the
three dimensional structure of the protein is the most important important target to
align on, however additional attributes are important to integrate as well, especially
for more distantly related proteins, or more extreme mutations which may have sig-
nificantly affected the structure. Examples of these additional attributes include the
amino acid sequence, hydrophobicity, and sub-groupings of three consecutive amino
acids.
As we have had previous success in incorporating additional information from
one dimensional (1-D) signals into time-frequency transformations, in this chapter we
propose a generalization to three dimensions (3-D). These additional dimensions allow
for a concise representation of the structure, as well as time-frequency modulation to
represent additional attributes.
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3.2 Protein-to-Waveform Mapping Model
3.2.1 Selection of Highly-Localized Waveform
Current methods of protein structure alignment using waveform mapping do not
consider all possible multiple global and local conformations [88]. Including direc-
tionality between linked amino acids as part of the waveform mapping leads to more
successful structural alignment [89]. In particular, a protein-to-waveform mapping
model needs to allow for translations and rotations in the three dimensional (3-D)
plane to better represent the protein structure. As a result, there is a need for a
parametric waveform representation with a unique 3-D shape and parameters that
can be selected to identify changes in 3-D conformations. An important motivation
for a 3-D basis representation of protein structures is the fact that distantly related
proteins need not have similarity over the entire structure. Similarities can be local-
ized, and if the representation is linearly separable, it can be used to analyze similar
segments over shorter structure lengths.
For multiple attribute mapping, we use a 3-D Gaussian waveform that is highly-
localized in the higher-order six dimensional time-frequency plane. The multivariate
Gaussian waveform, g(t), is defined across a 3-D time-domain, (tx, ty, tz), with co-
variance matrix Σ as
g(t; Σ) = Ag (2pi)
−1.5|Σ|−0.5 e−0.5 tTΣ−1t , (3.1)
where t = [tx ty tz]
T, Ag is a normalization constant so that the Gaussian waveform
has unit energy, |Σ| is the determinant of Σ, and T denotes vector transpose. The
Gaussian waveform can also be transformed by changing its amplitude a(t) and its
phase function ψ(t) to obtain
s(t; Σ,ψ) = a(t) g(t; Σ) e−j2piψ(t) . (3.2)
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For example, the Gaussian signal can be time-shifted and frequency-shifted
s(t; Σ, τ ,ν) = g(t− τ ; Σ)ej2pi (t−τ )Tν , (3.3)
where τ = [τx τy τz]
T and ν = [νx νy νz]
T are the time shift and frequency shift trans-
formations along each axis, respectively.
3.2.2 Mapping Geometric Structure Attributes
We consider two neighboring amino acids, Ai and Ai+1, where each amino acid is
centralized about a single α-carbon [107]. The 3-D geometric atomic coordinates of
the ith amino acid are given by xi = [xi yi zi]
T; these 3-D structure coordinates are
specified in protein data bank (PDB) files [1]. For the 3-D protein-to-waveform map-
ping, we use the time-shifted and frequency-shifted Gaussian waveform s(t; Σi, τ i,νi)
in (3.3). We then select the time-shift parameter τ i, frequency-shift parameter νi,
and covariance matrix Σi to represent the neighboring Ai and Ai+1 amino acids.
The time-shift parameter τ i = [τx,i τy,i τz,i]
T is selected such that the waveform in
Equation (3.3) is centered between adjacent α-carbons. Thus,
τx,i = (xi − xi+1)/2,
τy,i = (yi − yi+1)/2,
τz,i = (zi − zi+1)/2,
corresponding to the mid point between Ai and Ai+1.
The covariance of the 3-D Gaussian is selected to model the amino acids 3-D
orientation. Specifically, we want the energy of the Gaussian to be localized in the
region between the two α-carbons such that xi and xi+1 appear as the two outer-
most points on the 3-D Gaussian function in the mapped (tx, ty, tz) plane. Using
eigendecomposition of the Gaussian covariance matrix, we can obtain the eigenvector
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matrix that can be shown to correspond to the orientation or rotation matrix from
3-D point xi to xi+1. The geometric design of the rotation matrix is thus based on the
spherical angles description, (φi, θi), of the vector between these two points. Using
the coordinates for Ai and Ai+1, the angles are obtained as
φi = arctan
(
yi − yi+1
xi − xi+1
)
, θi = arccos
(
zi − zi+1√
di
)
(3.4)
where
di = (xi − xi+1)2 + (yi − yi+1)2 + (zi − zi+1)2. (3.5)
Using the angles in (3.4), the rotation matrices [108] are given by
Rφi =

cos(φi) −sin(φi) 0
sin(φi) cos(φi) 0
0 0 1

Rθi =

cos(θi) 0 −sin(θi)
0 1 0
sin(θi) 0 cos(θi)
 .
The designed covariance matrix Σi is then calculated as
Σi = Rφi Rθi ΛiR
T
θi
RTφi (3.6)
where Λi = diag([di/36 0.1 0.1]). The scaling on each axis by Λ is chosen to
concentrate the energy between the amino acid locations, and to limit the amount of
overlap between adjacent Gaussian waveforms.
The frequency-shift parameter νi = [νx,i νy,i νz,i]
T is selected to provide direction-
ality information. Fixing the frequency-shift along each plane demonstrates pointing
from xi to xi+1; the negative of the same frequency demonstrates pointing from
64
xi+1 to xi. Note that the time and frequency-shifted Gaussian waveform is sampled
compactly so that the correlation between two mapped amino acids with different
parameters is almost zero. An entire protein consisting of N amino acids is then
modeled by the sum of N − 1 time and frequency-shifted Gaussian waveforms
s(t) =
N−1∑
i=1
s(t; τ i,Σi,νi) . (3.7)
3.2.3 Mapping Sequence and Function Property Attributes
The sequence and function property attributes can be mapped using other wave-
form transformations. For example, the time-varying phase function in (3.2) can be
chosen to be a quadratic function along each axis with an amplitude modulation
selected to preserve waveform orthogonality.
3.3 Protein Multi-Alignment Metric
The 3-D structure protein alignment requires rotating and shifting a query protein
and a database protein to find their globally maximum alignment. We define the set
of α-carbons describing the 3-D geometric atomic coordinates of N amino acids as
X = [x1 x2 . . . xN ]. As we are using the location of amino acid α-carbons to model
the location of the proteins, we only need to shift and rotate those point sets.
Structure Alignment Searching the entire 3-D space of feasible shifts and rotations is
computationally prohibitive, so we utilize a search procedure where the 3-D protein
structures are always in a position of at least partial alignment. The procedure
focuses on a set of three consecutive amino acids Ai−1, Ai, Ai+1, with corresponding
3-D coordinates xi−1, xi, xi+1. The coordinates are shifted to place xi at the origin
[0 0 0]. The origin-shifted amino acid structure, with coordinates (X− xi), is then
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rotated using rotation matrix Qi. This matrix is obtained based on the following
conditions:
(a) the vector from xi to xi+1 lies along the x-axis;
(b) the vector from xi to xi−1 lies in the x-y plane.
The 3-D coordinates of the origin-shifted and rotated structure are given by
XR = Qi(X− xi) . (3.8)
Figures 3.1 and 3.2 illustrate a short protein sequence before, and after shifting and
rotating respectively.
Figure 3.1: A Short Protein Sequence in an Arbitrary Coordinate System.
The structure is then mapped using the protein-to-waveform Gaussian mapping
described in Equations (3.3) and (3.7). The mapping is applied to both the query
and database structures. Considering a query amino acid A
(q)
i and a database amino
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Figure 3.2: A Short Protein Sequence Shifted and Rotated to the 3-D Coordinate
Origin.
acid A
(d)
j , the structure mapping for each amino acid results in the 3-D Gaussian
waveforms s(q)(t; τ i,Σi,νi and s
(d)(t; τ j,Σj,νj), respectively. We obtain a structure
alignment score (Str) by calculating the inner product between these 3-D Gaussian
waveforms as
Stri,j =
∫
s(q)(t; τ i,Σi,νi) s
(d)(t; τ j,Σj,νj)dt . (3.9)
Sequence Alignment The sequence alignment score (Seq) is calculated by looking
at the corresponding rows and columns of the relevant block substitution matrix
(BLOSUM), in this case, BLOSUM62 as
Seqi,j =
1
11
BLOSUM62(A
(q)
i , A
(d)
j ) . (3.10)
Note that this score is normalized to have a maximum match score of 1.
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Hydrophobicity Alignment The hydrophobicity alignment score (Hydr) is calculated
using
Hydri,j =
1
13.64
(13.64− |hi − hj|) (3.11)
where hi and hj are the hydrophobicity values of amino acids A
(q)
i and A
(d)
j , re-
spectfully, in units of kJ/mol. The normalization constant 13.64 results in a maximum
score of 1 when the amino acid sequences are identical and a score of 0 when the hy-
drophobicity values of the two amino acids are maximally different.
The overall location, structure, and function (LoStrFn) alignment score is obtained
by combining the three scores in Equations (3.9)-(3.11). In particular, it is given by
SCi,j = Stri,j + Seqi,j + Hydri,j . (3.12)
Note that each of the scores can be weighted differently based on the available
information on the importance of each attribute. In additional to computing separate
scores and adding them together, as is done above in Equation 3.12, it is possible, but
not implemented here, to integrate all of the information into a single time-frequency
waveform where the inner product evaluated in Equation 3.9 would compute the
entire score, and not just the structure score.
When all LoStrFn attributes are combined, we can use a single overall metric for
protein alignment. An alternative method of obtaining a LoStrFn alignment metric
is by performing each attribute mapping and corresponding alignment separately
and then combining the three resulting metrics together to obtain a single metric
[80]. This approach is less computationally intensive since the alignment algorithm
becomes more complex as the signal transformation parameters increase. One possible
way to perform each attribute mapping and alignment separately is by matching the
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one dimensional sequence information using the BLOSUM62 matrix and the matching
pursuit decomposition method from [30]; and by matching the property amino acid
or substitution matrix information directly from tabulated available results.
3.4 Alignment Results
A local LoStrFn alignment is performed to identify regions of similarity within
long protein sequences that could be widely divergent. The metric score in (3.12) can
be used for local alignment. A global LoStrFn alignment involves finding regions of
similarity for the entire query protein. This alignment is computed using a structured
search across all possible time and frequency-shifts and rotations of the query and
database proteins. The 3-D structural alignment is performed for all three amino acid
combinations of the database and query sequences. This is done by cycling through
all of the possible combinations of Qi in (3.8) for both protein sequences.
To demonstrate the effectiveness of the LoStrFn alignment method, we compare
two human mutant ferrochelatase proteins. The mutations cause changes in the amino
acid sequence as well as the 3-D structure of the protein. Here, the 7 amino acid
query sequence (TSDHIET) is a sub-sequence of protein 2po5 and the 19 amino acid
database sequence (ILLVPIAFTSDCIETLYEL) is a sub-sequence of protein 2po7.
The location, geometry and hydrophobicity values for the two proteins are obtained
from the Protein Data Bank [1]. The 3-D protein structure waveform mapping in
the time-frequency plane for global alignment is demonstrated in Figure 3.3. The
structure of the two protein subsections are highly overlapping. The query protein,
2po5, is plotted in blue, while the database protein, 2po7, is plotted in green. The
global alignment scores for each attribute and the overall alignment scores are listed in
Table 3.1. As expected, the overall score improves protein similarity as it incorporates
the matching of different attributes that contribute toward the protein mutations.
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Score Type Score Values
3-D Structure 0.66 0.95 0.98 1.00 1.00 0.99
AA Sequence 0.45 0.36 0.54 -0.27 0.36 0.45
Hydrophobicity 1 1 1 0.57 1 1
Overall 2.11 2.31 2.52 2.3 1.36 2.44
Table 3.1: LoStrFn Matching Scores
Figure 3.3: Structure Slignment of Two Human Mutant Ferrochelatase Proteins:
Query 2po5 Protein (Blue) and Database 2po7 Protein (Green) From [1].
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Chapter 4
PHYSICS-BASED SEA CLUTTER MODEL FOR IMPROVED DETECTION OF
LOW RADAR CROSS SECTION TARGETS
4.1 Detection Problem in Rapidly Varying Sea Clutter
In highly cluttered environments, such as in heavy sea clutter, the problem of
detecting a small target is very challenging. It is thus important to understand the
statistical characteristics of the complex sea environment and obtain physics-based
models that we can incorporate into our detector algorithm designs. This can lead to
an increase in detection performance by using the model to minimize the impact of
the environment.
Sea clutter is often characterized by the compound Gaussian sea clutter model.
While described mathematically later in this chapter, the concept behind this model
is that sea clutter is a summation of large amplitude and wavelength waves, called
gravity waves, and smaller amplitude and wavelength waves called capillary waves.
The capillary waves are are quick to decorrelate, and the strength of these random
reflections is modulated by the size of the gravity waves. Thus, these large, quickly
changing clutter reflections present a significant obstacle to the detection of electro-
magnetically small targets.
4.2 Physics-based Finite-Difference Time-Domain Sea Clutter Simulation
The sea clutter generation model includes two main processes. The first process is
the generation of a three-dimensional (3-D) random dynamic sea surface that moves
according to the governing physics of water waves as driven by the wind; the waves
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include gravity waves whose restoring force is gravity, and capillary waves whose
restoring force is water surface tension. The second process includes two dimen-
sional (2-D) finite-difference time-domain (FDTD) simulations. It is based on using
Maxwell’s equations to propagate radar pulses through the FDTD domain, where the
incident electromagnetic (EM) field impinges on the sea surface and scatters. The
implementation of a teleportation window [94] in the FDTD simulations separates
the scattering field or clutter from the total field; it is then propagated to the far field
and collected for processing. The 2-D FDTD simulations involve individual radar
pulses incident on single cuts of the dynamic 3-D sea surface. The sea is modeled as a
perfectly conducing surface (water cells are perfect electric conductors). As the radar
pulse duration is on the order of nano seconds, the surface is a static snapshot during
each pulse simulation but is propagated in between simulations of subsequent pulses
according to the pulse repetition time. For a single radar pulse, multiple down-wind
cuts of the 3-D sea surface are simulated. These cuts are strategically spaced in the
cross-wind direction in an attempt to collect scattering samples of the 3-D sea and
capture scattering across the radar footprint area on the sea surface. The superposi-
tion of radar backscatter collected from the multiple down-wind sea cuts constitutes
quasi-3-D sea clutter. The features of the sea surface are developed in stages: incorpo-
rating 2-D static gravity waves and developing a capillary waves model, implementing
a spreading function to expand into 3-D, and superimposing the capillary waves on
the gravity waves while mathematically giving each random wave its respective phase
velocity.
The gravity waves component of the 2-D sea surface are generated as described in
[109]. The height f(yn) of the 2-D sea surface at points yn along the surface is given
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by
f(yn) =
1
L
N/2−1∑
m=−N/2
F (Km) exp (jKmyn) (4.1)
where
F (Km) =
√
2piLW (Km)Rm, (4.2)
Rm is a zero-mean, unit-variance Gaussian random variable r(0, 1) for m = 0, N/2,
and
Rm = ((r(0, 1) + jr(0, 1))/
√
2 (4.3)
for m = 1, . . . , N/2− 1. The function
W (Km) = (α/(4|Km|3) exp (−βg2/(K2m U4)) (4.4)
is the P-M sea spectrum [110], where L is the sea surface length in meters, N is
the number of surface sampling points, Kn = 2piΛn is the wave number of the ocean
wave, Λn is the ocean wave wavelength, β = 0.74, α = 0.0081, g = 9.81 m/s
2 is the
gravitational constant, and U is the wind speed in m/s.
The slope of the gravity waves versus time at any point on the sea surface is
proportional to the amplitude modulation of the clutter (or the clutter texture) re-
turning from that point of the sea, so it is vital that the instances of gravity waves
are generated correctly. In order to verify that the gravity waves model is correct,
we simulated 2-D FDTD incident EM plane wave illumination on our gravity wave
surface f(yn). The parameters of the EM simulations were chosen based on infor-
mation found in previous work. The proper discretization of the Pierson-Moscowitz
(P-M) sea surface, to capture scattering from relevant details of the sea, is given in
[111]. We chose an extreme case to reproduce for generating the far field scattering
from large details of the sea (gravity waves), following an FDTD simulations study
in [112]. The sea details of interest are relatively large gravity waves, with a sea state
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of 7 (wind speed of 20 m/s) and a significant wave height of roughly 6 meters. Thus,
to capture details of this size, the free space EM illumination wavelength is chosen as
λ0 = 7.49 m. The sea surface is sampled at λ0/16 intervals. The discretization cell
in our FDTD space is λ0/16, and the plane wave EM illumination angle of incidence
is 20 degrees above the horizon. Using these settings, we simulated 40 independent,
completely decorrelated, random instances of the gravity wave surface of total length
160λ0 m.
The scattering from the gravity waves is propagated to the far field over the
horizon, where evidence of the changing slopes of larger gravity waves can be seen
from one instance of sea to the next. The far field scattered intensity of 3 instances
and the average of 40 instances (black curve) are shown in Figure 4.1. These results
Figure 4.1: Far Field of 2-D Gravity Waves.
demonstrate that we have a valid simulation of large realistic sea surface details in
the EM environment using the FDTD computational EM method. The results also
show that the 2-D gravity wave surface is correctly generated.
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To include the smaller details of the sea surface, we develop an energy spectrum
to generate capillary waves in the same manner that the P-M spectrum is used to
generate gravity waves. The spectrum is obtained using results from other capillary
wave studies. We first estimate an exponential function that relates the wind speed
U and capillary wave wavelength Λ [113]. The total kinetic and potential energy
of water waves is given by E = ρpiA2, where A is the wave amplitude and ρ is the
density of water [114], and the amplitude of the capillary wave of greatest height
is 2A = 0.73Λ [115]. Using these relations, we estimate the energy spectrum for
capillary waves using
w(Kn) = (4αcρpi
3U/|Kn|2) exp (−(KB − βcKn)/(β2cKn))2 , (4.5)
where KB = 2piΛB, ΛB is the wavelength boundary between gravity and capillary
waves, αc = 0.0445, and βc = 0.6. This expression does not account for other
phenomena such as the effect of the local gravity wave slope and the angle of incidence
of the local wind and instantaneous wind speed. However, it yields roughly the correct
capillary wave heights based on experimental data [113] and is suitable for our study.
Note that, although capillary and gravity waves are generated by the same approach,
we continuously change the random number sets to prevent repeating capillary wave
patterns.
The waves are propagated using the phase velocity equation
v2p =
T
ρ
K +
g
K
, (4.6)
where T is the surface tension per length, ρ is the water mass density, g is gravity
acceleration, K = 2pi/Λ is the water wave number, and Λ is the wavelength of the
water wave [114]. The first and second terms in (4.6) correspond to the velocity of
capillary waves and gravity waves, respectively. Each wave is given a phase velocity
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φn =Knyn − ωnt, following (4.6), where
ωn = (|Kn|2(TKn/ρ+ g/Kn))0.5. (4.7)
To expand to 3-D surface, we implement a spreading function as in [116]. Super-
imposing the moving capillary waves on the moving gravity waves results in the full
dynamic and random 3-D realistic sea surface.
The speckle component of sea clutter is backscatter from capillary waves. A simple
test to demonstrate that our capillary weaves scatter clutter in as similar fashion as
the real sea is to calculate the Pearson’s correlation coefficient of the first returning
clutter pulse with all returning pulses. If the capillary waves have the correct motion,
the speckle component of the clutter decorrelates in the time that real sea speckle
decorrelates, which is on the order of 10 ms. For this test, in order to best observe
the capillary waves, we chose to use X-band radar, since the EM wavelength is on
the order of the capillary wave wavelength and amplitude. We simulated 100 radar
pulses incident on a single cut of time-varying 3-D sea, using 1 ms pulse repetition
time, to capture the effect of the clutter. The correlation results are plotted in Figure
4.2, which shows that the speckle decorrelated in approximately 15 ms.
4.3 Detection Methods of Low Radar Cross Section Targets
We consider a radar system for detecting a target in heavy sea clutter. The target
is assumed to have low radar cross-section due to its actual size and its relative size
in relation to the wavelength of the illuminating radar. We assume that the radar
system transmits a pulse train of K identical pulses, s(t), which scatter off sea surface
scatterers, and if present, the target. The two detection hypotheses describing this
scenario for the kth transmit signal, k= 1, 2, . . . , K, and the ith sea surface scatterer
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Figure 4.2: Decorrelations of the Radar Returns From the Simulated Sea Clutter
Occur Over Approximately 15 ms.
are given by
H0 : xk(t) =
∑
i
ak,i s(t− ti) + w(t)
H1 : xk(t) = bk s(t− t0) +
∑
i
ak,i s(t− ti) + w(t) .
Under hypothesis H0, we assume that that received signal consists of multiple scat-
terers with complex scattering coefficients ak,i and time delays ti and white Gaussian
noise w(t). Under hypothesis H1, we assume that, in addition to the scatterers and
noise, the target is also present with a scattering coefficient bk at time delay t0. In
both hypotheses, the signals are sampled using as sampling period Ts to yield the
discrete time sequence xk[n] =xk(tTs), n= 0, . . . , N − 1. For the rest of the chapter,
we assume that the clutter-to-noise ratio is very high and that the effects of noise
on detection can be ignored. The pulse train radar waveform transmission scheme
described above, is illustrated in Figure 4.3.
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Figure 4.3: Illustration of the Radar Waveform Pulse Model.
4.3.1 Generalized Matched Filter Detector
We derive the generalize matched filter (GMF) detector, that under hypothesis H1,
assumes that the discrete-time incident signal s[n] is known and deterministic but the
target time-delay is unknown. After first estimating the time-delay using maximum
likelihood estimation, the GMF detector is obtained by maximizing the probability
of detection for a fixed false alarm rate. For our signal model, the discrete-time
matched filter output corresponding to the kth pulse at the `th lag, `= 0, . . . , N − 1,
with estimated n0, is given by
rk[`] = bkzs[`− n0] +
N−1∑
n=−(N−1)
zs[n] dk[n+ `] (4.8)
where the autocorrelation function of the transmit signal s[n] at lag ` is defined as
zs[`] =
N−1∑
n=0
s[n]s∗[n− `], (4.9)
and
dk[`] =
∑
i
ak,i (4.10)
is the aggregate scattering coefficient from all of the clutter scatterers that fall within
the `th range bin. The decision threshold γ is set based on the distribution of rk[m]
and by fixing either a desired value of false alarm rate PFA or probability of detection
PD.
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4.3.2 Subspace Clutter Suppression Detector
The GMF detector is not expected to perform well for low radar cross section
(RCS) targets in heavy sea clutter. In such cases, the clutter is much stronger than
the signal, and for reasonable values of PD, the number of false alarms is large. This
is expected as matched filtering does not involve clutter mitigation. The subspace
clutter suppression (SCS) detector decomposes the signal into subspaces consisting of
mostly clutter or mostly target energy. The detection performance is improved when
only the subspaces that are orthogonal to the clutter are processed.
We assume a Swerling I point target so that the complex reflectivity of the target
b = [b1 b2 . . . bK ]
H
for all K transmit pulses has a zero-mean complex Gaussian distribution with covari-
ance matrix σ2IK , where IK is the (K ×K) identity matrix and H denotes complex
transpose. For each of the K transmit pulses, the matched filter output at the `th
lag or range bin can be written in vector form as
r` = b zs[`− n0] +
N−1∑
n=−(N−1)
dn+` zs[n] (4.11)
where
r` = [r1[`] r2[`] . . . rK [`]]
H,
dn+` = [a1,n+` a2,n+` . . . aK,n+`]
H.
The covariance matrix of the matched filter output depends on both the target and
clutter characteristics, and it is given by
R` = E[r`r
H
` ] = E[bb
H]|zs[`− n0]|2
+
N−1∑
n=−(N−1)
N−1∑
l=−(N−1)
E[dn+` d
H
l+`] zs[`] z
H
s [l] . (4.12)
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The matrix can be re-written in the form of the compound Gaussian sea clutter model
as
R` = σ
2IK |zs[`− n0]|2 +
N−1∑
n=−(N−1)
Φ Ln+` |zs[n]|2 (4.13)
where Φ is the speckle covariance matrix and L` is the sea clutter texture component.
Some existing detection methods use the above formulation to estimate the texture
and speckle clutter components for use in a generalized likelihood ratio test. While a
reasonable approach, estimating the texture and speckle clutter components is com-
putationally intensive, and it is often performed using expectation maximization or
another iterative method. A less computationally intensive approach, that also yields
reasonably good results, estimates sample covariance matrix from the data in all the
range bins in one coherent processing interval as
R =
1
N
N−1∑
`=0
(r` − r¯`)(r` − r¯`)H (4.14)
where r¯` is the mean value of r` at the `th lag. To suppress the clutter from the re-
ceived signal, we decompose R into the eigenvector matrix Q and diagonal eigenvalue
matrix D to obtain
R = QDQH, (4.15)
where we assume that the eigenvalues along the diagonal of D are sorted in descending
order. The eigenvector matrix Q is also sorted according to the ordered eigenvalue
matrix.
Negative SCR values imply that the larger eigenvalues and associated eigenvectors
are due to sea clutter and define the eigenvectors that we want to suppress. We form
a matrix Qc from the J < K eigenvectors of Q whose columns are associated with the
smallest J eigenvalues of R. The projected signal onto the signal subspace is given
by QcQ
H
c r`; this is the clutter suppressed signal that results in a larger SCR than
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r`. Using the clutter suppressed signal for target detection results in an improved
detection performance when compared to that of the GMF detector.
4.4 Simulation Results
In order to evaluate the performance characteristics of the GMF and SCS detec-
tors across a range of SCRs, we need to vary the strength of the clutter and target
reflections. Varying these parameters is straightforward when clutter realizations are
simulated using the compound Gaussian model or any other statistical model. How-
ever, this is not the case when using our proposed sea clutter generation model. The
data generated from the physics-based FDTD model is controlled by physical prop-
erties of the sea surface (such as the size and shape of the waves), the target (such
as the size of an object), and the radar (such as the radar beamwidth). While we
have direct control over the strength of the clutter and target reflections, we do not
know the exact numerical value of the SCR. This is because the reflected signal is
a combination of both direct reflection from the target as well as delayed reflections
from the sea surface; this makes it difficult to calculate just the target component or
just the clutter component of the received signal.
As we cannot control the numerical SCR values, we cannot specify the exact
detector performance, such as the probability of detection versus the probability of
false alarm, for a given SCR. We can, however, evaluate the detector performance
for relative ranges of SCR values, that is simulate scenarios for relatively larger or
smaller SCRs. In order to accomplish this, we keep all parameters but one constant,
and then we vary that one parameter to affect the SCR. In the following simulations,
we hold the target size and radar beamwidth constant but increase the size of the
waves resulting in varying SCR values. We consider three such scenarios to illustrate
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the detector performance across a wide range of SCRs. The SCR in these scenarios
is ordered as these scenarios, SCR1 > SCR2 > SCR3.
The first scenario shows detection performance for a large SCR value. The receiver
operating characteristic (ROC) curves, demonstrating probability of detection PD as
a function of the probability of false alarm PFA, for the GMF and SCS detectors at
SCR1 is shown in Figure 4.4. As expected, GMF detector outperforms SCS because
of the positive SCR. When operating on a positive SCR the SCS detector removes
the dominant mode, which in this case happens to be the signal of interest, and as a
result its performance is poor.
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Figure 4.4: ROC Curves Comparing the Performance of the SCS and GMF Detectors
Using SCR1 Values.
In the second scenario, SCR2, the SCR is now low enough that the SCS detector
is removing clutter power from the radar returns, and is improving the SCS detector
ROC curve. At this SCR, the GMF detector is performing much worse than before,
and does not perform as well as the SCS detector. The ROC curves for both the
GMF and SCS detectors are plotted in Figure 4.5.
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Figure 4.5: ROC Curves Comparing the Performance of the SCS and GMF Detectors
Using SCR2 Values.
The ROC curves for the third scenario, SCR3 are shown in Figure 4.6. Here, the
SCR is even more negative than in Figure SCR2, and the processing gain of the SCS
detector over the GMF detector has increased.
The simulated results shown in Figures 4.4, 4.5 and 4.6 use the sea clutter gen-
eration model with K=31 pulses; for the SCS detector, only the first eigenmode was
suppressed (J=30). The number of clutter eigenvectors is data dependent and is of-
ten chosen by looking for an abrupt drop-off value in the eigenvalue amplitude from
the ordered list of eigenvalues. For K=31, this drop-off value occurred after only one
eigenvalue. We expect that for larger values of K, more than one clutter eigenmode
would need to be suppressed. However, as in this set of simulations we considered a
constant pulse repetition frequency, larger values of K resulted in poorer detection
statistics because the sample covariance matrix was then computed from decorrelated
sea clutter data.
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Figure 4.6: ROC Curves Comparing the Performance of the SCS and GMF Detectors
Using SCR3 Values.
Decreasing the SCR beyond what it is in the SCR3 results in poorer performance
for both the SCS and GMF detectors. While the clutter removed from the first
eigenmode using the SCS detector improves the SCR, it does not remove enough
clutter to continue improving the performance. A more complex algorithm would
need to be developed to automatically select the number of eigenmodes which should
be removed.
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Chapter 5
CONCLUSIONS AND FUTURE WORK
5.1 Conclusions
The dissertation proposed signal processing methods for improving detection per-
formance in molecular biology and radar applications. The signal processing al-
gorithms included mapping biological sequences to signals and then using highly-
localized time-frequency representations to estimate epitopes and identifying mimo-
topes from one-dimensional sequences and to perform alignment in protein structures.
They also included an improved detector of a target in heavy sea clutter based on a
high-fidelity physics-based electromagnetics simulation.
Random sequence peptide microarray analysis requires the detection and iden-
tification of antibody epitopes from microarray peptide sequences to discriminate
between pathogens and diagnose diseases. This was achieved by first mapping charac-
teristics of peptide and epitope sequences to parameters of highly-localized Gaussian
waveforms in the time-frequency plane. After down-selecting the large number of
sequences from a microarray, time-frequency based matching methods were used to
estimate epitope candidates corresponding to specific pathogens. The performance of
the novel epitope estimation and identification method was demonstrated using eight
monoclonal antibodies. The candidate sequences that resulted in a stronger response
for one antibody over the others corresponded well with the actual epitope sequences
that generated the monoclonal antibodies. Using this method, we estimated exact
epitope subsequences for five of the eight monoclonal antibodies, and we estimated
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epitope subsequences which closely resembled the exact subsequences for the other
three monoclonal antibodies.
Initial results for the 330k array and a comprehensive description of the signal
processing algorithms on subsequence estimation were published in a book chapter
[117]. In [118] we present a more in-depth analysis which includes both epitope
estimation and mimotope identification. We have also performed some related work
on the adaptive learning of peptide features, using a smaller random sequence peptide
array with 10k peptides [119]. This work was supported in part by DTRA, and by
the Ira A. Fulton Schools of Engineering Dean’s Fellowship.
We demonstrated a novel method of protein alignment incorporating multiple
attributes by mapping them onto three dimensional (3-D) Gaussian waveforms and
multiple waveform transformations between neighboring amino acids in the protein.
In particular, we map information about a protein’s sequence location, structure and
characteristic properties, and use a combined matching score to obtain protein multi-
alignment. As demonstrated by an example with query and database proteins from
the Protein Data Bank, when multiple attributes are incorporated in the alignment,
the overall alignment score improves and can lead to information on mutations that
cause changes not only in the protein structure but also in the protein [32].
We have also considered a detection problem that made use of physics-based
modeling but in a different application area. Specifically, we considered the detection
of a low radar cross section (RCS) target in heavy sea clutter. The modeled sea clutter
was generated using a 3-D random dynamic sea surface with gravity and capillary
wave models. The model included gravity waves with gravity as the restoring force
as well as capillary waves where the restoring force is the water surface tension.
The generation model includes two dimensional (2-D) finite-difference time-domain
(FDTD) sea clutter simulations. We investigated a simple matched filter detector
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and a subspace clutter suppression detector, and we used the FDTD simulations to
compare the performance of the two detectors [120]. This work was supported in part
by ONR, and a Doctoral Fellowship from the ASU Security and Defense Systems
Initiative (SDSI) Institute. Note that some additional radar work was performed
related to waveform design [121].
5.2 Future Work
5.2.1 Random Sequence Peptide Microarray Epitope and Mimotope Estimation
Future research into processing random sequence peptide array data will focus on
improving the robustness of the algorithms presented in this dissertation. One of the
major conclusions of the random sequence peptide array epitope estimation was that
Pearson’s correlation coefficient is an excellent ranking metric. It selects the peptides
which do not fluoresce strongly relative to the median array response, yet are fluo-
rescing strongly relative to how those peptides fluoresce in other antibody samples.
It would be useful to confirm the results of this work with a new set of monoclonal
antibody samples where the data are collected using exactly the same procedures
such that the background fluorescence of all the samples are approximately constant.
Furthermore, sometimes there is cross-reactivity between monoclonal antibody sam-
ples which can lead to worse performance of the Pearson’s correlation coefficient as a
ranking metric. The algorithm could be modified to be tolerant of this cross-reactivity
in order, for example, for the epitope of Flag to be better estimated.
5.2.2 Protein Alignment Using Time-Frequency Encoded Waveforms
The work published in [32] included structural information in the 3-D Gaussian
time-frequency modulation. While the locational and functional information was in-
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cluded in the alignment score, it was not part of the time-frequency modulation in
Equation 3.12. Future work would involve incorporating that information into the
time-frequency transform, and doing so in a computationally efficient manner. Ad-
ditionally, this method of 3-D alignment could be tested using evolutionarily related
proteins from the Protein Data Bank.
When incorporating additional information into the time-frequency transforma-
tion, the computational costs of additional information must be considered. Three
dimensional alignment can be computationally intensive, because of the number of
samples required to numerically evaluate Equation 3.9. When incorporating time-
frequency modulation, the Nyquist sampling rate increases according to the band-
width of the modulation in each of the three dimensions. While the sampling rate
and resulting number of computations increases in a single dimension as O(N), where
N is the number of samples, the computational burden of evaluating Equation 3.9
increases as O(N3). This quickly becomes a significant computational burden, even
on modern computers. One way to mitigate this is to consider time-frequency modu-
lations which are a function of one dimension at a time, e.g. a sinusoidal modulation
in the tx dimension. This class of modulations allows for encoding additional infor-
mation without an overwhelming increase in computational costs.
5.2.3 Sea Clutter Mitigation For Electromagnetically Small Targets
The radar sea clutter processing results showed improved performance for specific
target and clutter geometries, and the problem should be extended to include more
complex targets, and additional orientations between the sea clutter, target, and radar
to establish the circumstances under which the target subspace and clutter subspace
are meaningfully separable. Future work could also include dynamically estimating
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the number of clutter eigenmodes to cancel, and quantifying how dynamic estimation
would affect the detection statistics.
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APPENDIX A
LIST OF ACRONYMS
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1-D one dimensional
2-D two dimensional
3-D three dimensional
AA amino acid
BLAST basic local alignment search tool
BLOSUM blocks substitution matrix
DNA deoxyribonucleic acid
DS-OCRC down-selected occurrence count
ELISA enzyme linked immunosorbent assay
EM electromagnetic
FDTD finite-difference time-domain
GMF generalized matched filter
LoStrFn location, structure and function
mAb monoclonal antibody
MBI median background intensity
MFI median fluorescence intensity
MPD matching pursuit decomposition
OCRC occurrence count
PCC pearson’s correlation coefficient
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PDB protein data bank
P-M pierson-moscowitz
RCS radar cross-section
RNA ribonucleic acid
ROC receiver operating characteristic
SCR signal-to-clutter ratio
SCS subspace clutter suppression
SFI standard deviation of the fluorescence intensity
SVM support vector machine
TF time-frequency
TIFF tagged image file format
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APPENDIX B
RESULTS FROM THE ESTIMATION OF SUBSEQUENCES OF
MONOCLONAL ANTIBODY SAMPLES
103
In Chapter 2, we proposed a time-frequency based signal processing algorithm for
estimating epitopes and identifying mimotopes for eight different monoclonal anti-
body samples. Here we provide, in detail, our results for all eight samples.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
PWFK 682 19 883 2,798
PWFN 781 18 726 2,390
ARLR 659 16 1,220 5,556
ARPF 593 15 869 9,512
AVWF 634 15 720 2,529
PWFF 430 15 730 2,327
RPWF 515 15 902 3,277
RWFN 184 15 929 65,535
YSAW 503 15 731 3,613
ARWF 278 14 902 65,535
Table B.1: Estimated Top 10 Subsequences of Length L = 4 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FEEQE 168 7 586 5,826
FFEEQ 117 7 636 5,826
VFFEE 87 7 676 5,826
ARWFN 54 6 931 65,535
AVNWF 64 6 760 187
PWFNK 139 6 848 2,144
WFNRL 30 6 1,010 1,704
ARLRP 120 5 1,098 4,613
ARRVR 30 5 1,980 4,142
DARWF 37 5 834 65,535
Table B.2: Estimated Top 10 Subsequences of Length L = 5 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FFEEQE 116 7 636 5,826
VFFEEQ 86 7 685 5,826
DARWFN 10 4 1,197 65,535
AWRGFN 7 3 997 1,692
FARLRE 9 3 1,183 3,327
FKYARL 24 3 1,208 2,414
HFFKAL 6 3 954 1,693
KARLRP 6 3 1,652 4,613
WFARLL 6 3 1,050 1,769
WFNGYA 12 3 938 1,470
Table B.3: Estimated Top 10 Subsequences of Length L = 6 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
VFFEEQE 85 7 694 5,826
YVFFEEQ 22 3 805 2,089
AALEKDG 2,000 2 630 16,310
ALEKDGY 111 2 701 16,310
AVARPFQ 2 2 1,849 2,182
AVGWQAR 3 2 1,922 16,130
AWRGFNY 3 2 997 1,616
FARLREY 2 2 1,415 1,647
FEEQERY 13 2 656 1,559
FFEEQER 23 2 759 1,559
Table B.4: Estimated Top 10 Subsequences of Length L = 7 Obtained When Algo-
rithm 1 Was Applied to mAb 2C11, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
GYDS 158 58 3,667 65,535
EYDS 129 32 4,337 65,535
DSWP 169 28 1,345 65,535
YDSR 127 27 1,611 65,535
DSHP 272 24 877 65,535
DSRP 303 24 942 65,535
EADS 180 24 1,275 53,944
YDSH 59 24 7,006 65,535
DADS 100 23 2,197 65,535
YDSK 113 23 2,129 65,535
Table B.5: Estimated Top 10 Subsequences of Length L = 4 Obtained When Al-
gorithm 1 Was Applied to mAb 4C1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
GYDSR 21 13 8,731 65,535
YDSRP 18 11 4,315 65,535
ADSWP 20 10 12,769 65,535
YDSHP 13 10 28,346 65,535
ADSVP 34 9 1,728 29,299
FEYDS 25 9 3,320 61,256
GYDSW 11 9 6,107 33,735
YDSKG 12 9 18,650 65,535
EDADV 22 8 3,751 30,830
GYDSH 11 8 15,211 65,535
Table B.6: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb 4C1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FDSVGG 4 4 38,206 65,535
FKQYDS 6 4 3,840 7,562
NGYDSR 6 4 14,295 65,535
PADSWP 5 4 14,259 65,535
PFDSVG 4 4 65,535 65,535
ADSWPP 5 3 12,244 15,036
APNDSG 4 3 50,593 65,535
ARPGYL 15 3 1,463 5,797
DADSVP 4 3 8,811 24,246
DADSWP 3 3 13,294 19,770
Table B.7: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb 4C1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AAWRFFK 2 2 5,601 9,043
AGPGYDS 2 2 8,704 11,930
APNDSGG 2 2 50,593 65,535
ARGPFAR 4 2 2,857 5,287
ARPFYAR 6 2 1,563 3,254
AVGPNWF 6 2 1,116 11,397
AWRHFNY 4 2 1,080 1,977
AYAFDSN 2 2 34,179 65,535
DADSWPW 2 2 7,805 13,294
DLAPKEY 2 2 3,538 5,732
Table B.8: Estimated Top 10 Subsequences of Length L = 7 Obtained When Al-
gorithm 1 Was Applied to mAb 4C1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
WDVA 272 55 17,534 65,535
DVAW 473 52 8,790 65,535
DSAW 442 46 8,763 65,535
WQEA 135 46 65,535 65,535
DAAW 385 40 11,101 65,535
DVSW 239 36 19,765 65,535
QEYA 323 35 37,316 65,535
EDVA 242 34 20,428 65,535
WFEA 267 34 8,875 65,535
EWDA 346 32 10,617 65,535
Table B.9: Estimated Top 10 Subsequences of Length L = 4 Obtained When Al-
gorithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
EDFRV 34 20 65,535 65,535
EWDVA 41 15 65,535 65,535
EDVAW 35 14 65,535 65,535
WFEGA 53 14 32,589 65,535
WDVAP 33 13 65,535 65,535
DAAWP 52 11 16,042 65,535
DVAWG 57 11 10,288 65,535
EWDAA 44 11 31,044 65,535
PWFEA 69 11 10,370 65,535
WDVAW 42 11 19,322 65,535
Table B.10: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
DFRVDW 22 8 35,188 65,535
FRVDWK 40 8 5,252 65,535
EDFRVD 6 5 65,535 65,535
EDVRPF 10 5 39,784 65,535
PWQEAS 7 5 65,535 65,535
AVWFEG 11 4 7,222 65,535
DVAWPF 12 4 22,508 65,535
EDARSG 6 4 34,672 65,535
EDVAPN 9 4 60,074 65,535
EDVAWP 6 4 65,535 65,535
Table B.11: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
DFRVDWK 22 8 35,188 65,535
EDFRVDW 6 5 65,535 65,535
FRVDWKH 33 4 2,294 65,535
AGNEYAL 4 2 38,101 65,535
APEDPED 167 2 830 65,535
APWFEDS 3 2 39,460 65,535
APWKEDS 4 2 34,151 65,535
APWNEAR 3 2 65,535 65,535
AQEYRPE 2 2 65,535 65,535
AVGPWQE 3 2 65,535 65,535
Table B.12: Estimated Top 10 Subsequences of Length L = 7 Obtained When Al-
gorithm 1 Was Applied to mAb A10, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
HSVV 618 196 16,682 65,535
RHSV 298 188 61,191 65,535
RRHS 78 17 4,082 65,535
PWFN 781 15 952 41,733
HPWF 632 14 1,069 15,186
PWHF 908 13 1,553 31,088
AAVW 611 12 1,436 43,546
AVRG 610 12 2,488 65,535
AWPF 562 12 1,033 41,005
FGAR 384 12 2,029 56,590
Table B.13: Estimated Top 10 Subsequences of Length L = 4 Obtained When Al-
gorithm 1 Was Applied to mAb Ab1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
RHSVV 209 186 65,535 65,535
RRHSV 26 16 19,861 65,535
VRHSV 11 8 23,648 65,535
ARHSV 27 5 558 65,535
AVRGF 62 5 2,013 52,630
AYAWF 45 5 828 6,867
AVWHF 168 4 1,647 25,080
AWHFS 19 4 2,254 19,262
FKEYL 37 4 1,645 12,231
FQYAL 67 4 1,095 23,112
Table B.14: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb Ab1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
RRHSVV 21 16 21,999 65,535
VRHSVV 10 8 26,646 65,535
ARHSVV 13 5 33,836 65,535
RHSVVW 5 4 20,292 61,580
FFEEQE 116 3 760 3,217
RGHSVV 18 3 13,371 53,733
RHSVVD 3 3 65,535 65,535
RWHSVV 21 3 3,146 51,425
AARPFA 12 2 2,229 27,035
AARWFF 6 2 764 4,349
Table B.15: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb Ab1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AFQYALV 3 2 1,485 2,275
APFKGRL 4 2 1,977 3,080
ARHSVVD 2 2 65,535 65,535
AVNWFLK 2 2 2,380 2,396
AVRHSVV 3 2 29,643 30,839
FFEEQEK 34 2 948 3,217
FSLKEWY 2 2 3,281 4,092
HVVLEEV 2 2 2,183 2,529
KYARNKR 3 2 2,099 3,054
LEEVLNL 167 2 1,121 15,534
Table B.16: Estimated Top 10 Subsequences of Length L = 7 Obtained When Al-
gorithm 1 Was Applied to mAb Ab1, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
PWHF 14 908 1,717 43,903
AWHF 13 872 2,055 32,972
VWHF 13 632 1,713 31,684
HPWF 12 632 1,264 15,576
PWFH 12 342 1,609 29,293
PWFK 12 682 1,306 39,635
WHFN 12 736 2,103 32,972
AARL 11 437 2,862 65,535
AVWG 11 662 1,420 64,190
AVWN 11 575 1,417 63,356
Table B.17: Estimated Top 10 Subsequences of Length L = 4 Obtained When Al-
gorithm 1 Was Applied to mAb Ab8, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
APEDP 7 172 1,107 33,036
AVGPW 7 97 1,428 23,273
DLWKL 6 63 1,174 10,504
EDPED 6 170 1,098 9,271
PEDPE 6 169 1,093 6,309
PWFAR 5 89 1,089 33,684
WFKYA 5 61 999 24,968
YALRV 5 55 1,500 12,950
AARLP 4 61 3,228 47,610
AAWHF 4 120 2,292 13,586
Table B.18: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb Ab8, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
APEDPE 6 167 1,093 6,309
PEDPED 6 167 1,093 6,309
LAPEDP 4 107 1,045 5,434
APWFKY 3 14 1,443 3,086
AVGPWF 3 30 1,312 23,273
EDPEDK 3 14 1,197 3,392
EDPEDS 3 39 1,031 6,309
FNYALR 3 14 1,685 5,422
PWFARP 3 11 1,467 3,281
WHFFKY 3 9 1,037 4,614
Table B.19: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb Ab8, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
APEDPED 6 167 1,093 6,309
LAPEDPE 4 107 1,045 5,434
PEDPEDK 3 14 1,197 3,392
PEDPEDS 3 39 1,031 6,309
APWFKYA 2 3 2,591 3,086
ARPWFHP 2 2 4,410 4,809
DHPADAW 2 2 1,962 2,479
DLDSDLW 2 2 3,713 5,483
DSDLWKL 2 2 3,713 5,483
DSWFKQG 2 2 1,458 1,534
Table B.20: Estimated Top 10 Subsequences of Length L = 7 Obtained When Al-
gorithm 1 Was Applied to mAb Ab8, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AVWF 634 15 944 17,499
WHFN 736 14 2,034 32,980
PWFN 781 13 1,053 41,133
AVPW 545 12 1,419 50,578
AWPF 562 12 1,098 46,024
GPWF 611 12 1,082 41,133
PFFN 381 12 1,293 31,135
PWFF 430 12 769 10,266
PWFK 682 12 1,206 41,829
VPWN 186 12 1,313 29,619
Table B.21: Estimated Top 10 Subsequences of Length L = 4 Obtained When Algo-
rithm 1 Was Applied to mAb DM1A, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
ALNRP 109 6 2,314 59,404
AALEK 2,058 5 2,364 43,563
ALEKD 2,100 5 2,369 43,563
DLWKL 63 5 1,075 7,130
LAWHF 62 5 1,534 7,388
AAPWF 82 4 1,298 31,956
ALLRP 62 4 1,776 28,850
ARHPW 104 4 2,002 10,599
AVRNK 45 4 2,205 23,019
AVWFF 60 4 895 7,230
Table B.22: Estimated Top 10 Subsequences of Length L = 5 Obtained When Algo-
rithm 1 Was Applied to mAb DM1A, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AALEKD 2,053 5 2,368 43,563
GPWFGY 11 3 1,137 4,580
LPAVFN 7 3 4,835 14,123
YALNRP 16 3 2,937 29,036
AAFYAL 6 2 1,591 2,287
AARWHF 10 2 2,850 12,048
AAVWFN 14 2 1,279 1,869
AAWARL 7 2 1,264 2,981
ADYRHF 3 2 3,295 3,474
AGPNWF 15 2 1,368 3,406
Table B.23: Estimated Top 10 Subsequences of Length L = 6 Obtained When Algo-
rithm 1 Was Applied to mAb DM1A, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AALEKDG 2,000 2 2,416 43,563
AALEKDN 3 2 7,503 17,762
APEDPED 167 2 947 5,464
APFFNLS 2 2 3,227 3,874
AVWRGNF 3 2 2,189 2,903
DAVWRGN 4 2 1,839 2,903
FGALLGW 2 2 1,317 1,606
FYALNRP 4 2 2,420 3,599
GPFYAKR 2 2 1,913 2,404
HGPFYAK 2 2 1,913 2,404
Table B.24: Estimated Top 10 Subsequences of Length L = 7 Obtained When Algo-
rithm 1 Was Applied to mAb DM1A, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
ALEK 2,143 1,325 34,896 65,535
LEKD 2,156 1,325 34,296 65,535
EKDG 2,026 1,324 42,310 65,535
AALE 2,117 1,323 36,032 65,535
KDGD 284 250 65,535 65,535
KDGE 278 191 65,535 65,535
KDGA 250 162 28,590 65,535
KDGW 276 153 10,010 65,535
KDGP 206 128 33,848 65,535
KDGH 237 90 17,798 65,535
Table B.25: Estimated Top 10 Subsequences of Length L = 4 Obtained When Algo-
rithm 1 Was Applied to mAb Flag, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
ALEKD 2,100 1,324 37,480 65,535
AALEK 2,058 1,323 40,477 65,535
LEKDG 2,002 1,323 44,588 65,535
EKDGD 268 250 65,535 65,535
EKDGE 215 191 65,535 65,535
EKDGA 250 162 28,590 65,535
EKDGW 253 153 14,352 65,535
EKDGP 182 128 50,613 65,535
EKDGH 232 90 19,087 65,535
EKDGL 134 81 14,198 65,535
Table B.26: Estimated Top 10 Subsequences of Length L = 5 Obtained When Algo-
rithm 1 Was Applied to mAb Flag, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AALEKD 2,053 1,323 40,576 65,535
ALEKDG 2,002 1,323 44,588 65,535
LEKDGD 267 250 65,535 65,535
LEKDGE 210 191 65,535 65,535
LEKDGA 250 162 28,590 65,535
LEKDGW 253 153 14,352 65,535
LEKDGP 181 128 51,217 65,535
LEKDGH 231 90 19,120 65,535
LEKDGL 134 81 14,198 65,535
LEKDGV 139 67 24,323 65,535
Table B.27: Estimated Top 10 Subsequences of Length L = 6 Obtained When Algo-
rithm 1 Was Applied to mAb Flag, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AALEKDG 2,000 1,323 44,588 65,535
ALEKDGD 267 250 65,535 65,535
ALEKDGE 210 191 65,535 65,535
ALEKDGA 250 162 28,590 65,535
ALEKDGW 254 153 14,427 65,535
ALEKDGP 181 128 51,217 65,535
ALEKDGH 231 90 19,120 65,535
ALEKDGL 134 81 14,198 65,535
ALEKDGV 139 67 24,323 65,535
ALEKDGS 64 55 65,535 65,535
Table B.28: Estimated Top 10 Subsequences of Length L = 7 Obtained When Algo-
rithm 1 Was Applied to mAb Flag, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
YDAP 91 44 6,400 65,535
DAPE 114 31 1,537 65,535
ADAP 285 27 864 65,535
DVPE 93 25 1,008 65,535
DAPG 168 24 1,122 65,535
DVPD 33 24 31,506 65,535
DAPV 112 23 1,027 65,535
YDVP 47 23 4,846 65,535
LDVP 153 20 823 65,535
FDAP 47 18 2,071 65,535
Table B.29: Estimated Top 10 Subsequences of Length L = 4 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
YDAPE 16 14 61,414 65,535
PYDAP 11 10 44,289 65,535
YDSPE 13 9 12,542 65,535
FDAPV 12 8 9,961 56,901
PFDAP 8 8 47,053 65,535
QYDAP 10 8 31,196 65,535
YDVPE 9 8 51,759 65,535
ADAPE 18 7 10,457 65,535
EDLPD 15 7 1,706 11,385
FYDAP 11 7 5,583 65,535
Table B.30: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
Subsequence OCRC DS-OCRC Mean MFI Max. MFI
FNYDSP 6 4 2,146 65,535
GYDAPE 4 4 59,422 65,535
NQYDAP 4 4 47,437 65,535
NYDSPE 4 4 11,997 65,535
AALEKD 2,053 3 694 11,285
ALEKDG 2,002 3 697 11,285
APYDAP 3 3 44,289 65,535
EDHPDG 3 3 4,984 40,563
EDLPDS 4 3 6,698 11,385
FFYDAP 3 3 6,135 65,535
Table B.31: Estimated Top 10 Subsequences of Length L = 6 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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Subsequence OCRC DS-OCRC Mean MFI Max. MFI
AALEKDG 2,000 3 697 11,285
FNYDSPE 3 3 19,861 65,535
PFNYDSP 3 3 19,861 65,535
AAWRNWQ 2 2 3,196 4,288
AGPYDAP 2 2 31,213 60,226
ANQYDAP 2 2 42,126 65,535
ARFDAPV 2 2 40,791 56,901
ARPFYAR 6 2 1,556 2,171
AVWFKSL 3 2 1,107 1,393
AVWRNQR 3 2 3,705 9,178
Table B.32: Estimated Top 10 Subsequences of Length L = 7 Obtained When Al-
gorithm 1 Was Applied to mAb HA, With Their Corresponding OCRC, DS-OCRC,
Mean MFI and Maximum MFI; the Estimated Subsequences Are Sorted in Descend-
ing Order According to the Values of Their Corresponding DS-OCRC.
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APPENDIX C
RESULTS FROM THE ESTIMATION OF SUBSEQUENCES OF DISEASE
SAMPLES
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In addition to the monoclonal antibody data that was analyzed in Chapter 2, we
also analyzed random sequence peptide array data which were collected using blood
samples of patients infected with four different diseases. The samples analyzed were,
Borrelia, Dengue, West Nile Virus, and Bordetella. Figures C.1 - C.4 are plots of
the down selected occurrence count for the top 10 estimated subsequences for these
four diseases. Two of the analyzed disease samples have literature-reported epitopes;
Borrelia and Dengle, whose epitopes are EDAK and AVHAD respectively. The epitope
for Borrelia was the first epitope estimate, while the epitope for Dengue was the fifth
epitope estimate.
Figure C.1: Estimated Top 10 Subsequences of Length L = 4 Obtained When Algo-
rithm 1 Was Applied to the Borrelia Disease Sample. The Estimated Subsequences
Are Sorted in Descending Order According to the Values of Their Corresponding
DS-OCRC.
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Figure C.2: Estimated Top 10 Subsequences of Length L = 5 Obtained When Algo-
rithm 1 Was Applied to the Dengue Disease Sample. The Estimated Subsequences
Are Sorted in Descending Order According to the Values of Their Corresponding
DS-OCRC.
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Figure C.3: Estimated Top 10 Subsequences of Length L = 5 Obtained When Al-
gorithm 1 Was Applied to the West Nile Virus Disease Sample. The Estimated
Subsequences Are Sorted in Descending Order According to the Values of Their Cor-
responding DS-OCRC.
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Figure C.4: Estimated Top 10 Subsequences of Length L = 5 Obtained When Algo-
rithm 1 Was Applied to the Bordetella Disease Sample. The Estimated Subsequences
Are Sorted in Descending Order According to the Values of Their Corresponding
DS-OCRC.
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